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Abstract 
I. Abstract 
 
 
 
Agrin is a large basement membrane (BM) proteoglycan expressed in many tissues in vertebrates, with 
particularly important function at the neuromuscular junction (NMJ) where it clusters acetylcholine 
receptors (AChRs) and maintains structural stability of postsynaptic specializations. In order to cluster the 
receptors it has to activate muscle-specific kinase (MuSK) through an indirect interaction via an unidentified 
myotube-associated specificity component (MASC). Agrin has also been implicated in providing structural 
integrity to different tissues by connecting the extracellular matrix (ECM) to α-dystroglycan (α-DG) which 
is part of a large supramolecular dystrophyn-associated glycoprotein complex (DGC) spanning the cell 
membrane and binding the actin cytoskeleton.  
Since an agrin orthologue was identified in the C. elegans genome, we decided to experimentally confirm its 
expression and characterize the protein. Based on the predicted sequences, we cloned the agr-1 cDNA and 
assembled the ORF of 4422 bp from overlapping fragments. The putative protein domain architecture 
shared high similarity to the vertebrate agrin, except for missing one laminin G (lamG) domain, 
serine/threonine-rich regions and the SEA module. Since in vertebrates agrin exists in two main isoforms 
varying at the amino (N)-terminal side, it was surprising to identify only one isoform in C. elegans. 
Likewise, additional alternative splicing that occurs at conserved sites in the vertebrate agrin orthologues 
having strong impact on the AChRs clustering activity, was not identified in AGR-1. Reporter constructs 
revealed agr-1 expression in the buccal epithelium of the pharynx, in four IL1 sensory neurons in the head, 
and the distal tip cell (DTC) of the gonad, but surprisingly no expression was found in the muscles or the 
motoneurons innervating them. The specific anti-AGR-1 antibodies detected the protein in the basement 
membrane of the pharynx.  
We analyzed several agr-1 mutant strains and performed many different assays with the goal to identify its 
function. No defects related to the NMJ could be found and some indications suggested that it might be 
implicated in the gonad migrations through genetic interaction with other factors. Based on the expression 
pattern in the head neurons and pharynx, we expected a sensory or feeding-related function but did not see 
clear defects. AGR-1 probably acts in parallel with several other proteins in a redundant fashion.  
This is the first characterization of an invertebrate agrin orthologue which sets a substantial basis for further 
research. 
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II. Introduction 
II.1. Agrin: protein with many faces 
II.1.1. Historical perspective 
Agrin is a large proteoglycan with a prominent function at the developing neuromuscular junction (NMJ) 
where it plays a pivotal role in the formation and maintenance of the acetylcholine receptor (AChR) clusters. 
Agrin was discovered more than two decades ago on the basis of its ability to induce clustering of AChRs 
on cultured myotubes. The observation that some trophic factors from the basal lamina extract of electric 
ray (Torpedo californica) were able to induce AChRs clustering on muscles in vitro [1] led to the 
identification of agrin. The protein was subsequently purified from the extract of the synapse rich Torpedo 
electric organ and, based on the observed aggregating activity, was named “agrin”, coming from Greek 
“ageirein” which means “to assemble” [2].  
Further studies revealed that agrin is synthesized by motor neurons, transported down their axons, released 
into the synaptic cleft and stably integrated into the synaptic basal lamina (BL), a specialized thin layer of 
the extracellular matrix (ECM) [3-5]. Based on these findings McMahan proposed the ‘agrin hypothesis’, 
which states that agrin is a nerve-derived synaptic organizing molecule [6]. As an additional support to the 
hypothesis, it was demonstrated that purified agrin, when added to the cultured myotubes, induces the 
AChRs aggregation in a dose-dependent manner. Moreover, when mixed (chick and rat) nerve-muscle co-
cultures in vitro were treated with the species-specific anti-agrin antibodies, it was confirmed that 
exclusively agrin released from motor neurons is responsible for the AChRs clustering [7].  
 
II.1.2. Protein architecture of vertebrate agrin 
 
So far agrin has been cloned from several vertebrate species including rat [8], chick [9,10], marine ray 
(Torpedo californica) [11], and man [12]. In all these species, the agrin gene encodes a large protein of 
more than 2000 amino acids with approximate size of 225 kDa. With additional glycosylation the molecular 
weight reaches up to 400-600 kDa (reviewed in [13]). Agrin exists in several isoforms with distinct 
expression patterns. The protein is localized particularly in the basement membrane, or stays attached to the 
membrane in tissues devoid of it.  
Domain architecture of agrin is characterized by repetitive modules homologous to domains found in other 
basal lamina proteins, namely: nine Follistatin-like domains (FS), that bear homology to Kazal-type 
protease inhibitor domains; two laminin EGF-like domains (LE); two serine-thereonine-rich regions (S/T) 
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flanking a domain common to sperm protein, enterokinase, and agrin (SEA); four EGF domains; and three 
laminin globular domains (lamG) (Introduction, Fig. 1) [8,9].  
At least three O-linked carbohydrate attachment sites for glycosaminoglycan (GAG) side chains are found 
within the S/T-rich region [14]. It was experimentally confirmed that agrin can be glycosylated with both 
heparan and chondroitin sulphate glycosaminoglycan chains [15]. In addition, agrin harbors several 
consensus sites for N-linked sugar modifications, (for a review, see [13]). Glycosylation is important for 
agrin binding to a membrane-linked protein α-dystroglycan (α-DG) and for the clustering activity at the 
neuromuscular synapse development. Early in vitro experiments on glycosylation-deficient myotubes 
demonstrated the impairment of AChRs clustering, suggesting the importance of glycosylation for this 
process [16].  
 
 
Fig. 1. Protein architecture of the vertebrate agrin isoforms. The SN and LN isoforms are presented; 
follistatin-like domains (purple, FS); laminin-type EGF domains (yellow, LE); serine-threonine rich region 
(green, S/T); sperm enterokinase and agrin domain (lilac, SEA); EGF domains (blue, EG1); laminin 
globular (beige, LG); (Source: [13]) 
 
Several alternative isoforms of agrin have been identified in vertebrates, with the variations at the amino 
(NH2)-terminus and alternative splicing in the carboxy (COOH)-terminal part. A longer amino (N)-terminal 
isoform (LN) contains a cleaved secretion signal (SS) followed by an N-terminal agrin (NtA) domain [10]. 
The NtA domain confers binding to domain I/II of the laminin γ1 chain in the basement membrane [17,18], 
thereby immobilizing agrin in the basal lamina. Originally identified in the chick, the NtA domain was 
found to be highly conserved in human, bovine, mouse [17,19] and predicted in the rat genome under the 
NCBI entry number AF250032. 
The shorter N-terminal agrin isoform (SN), which was first identified in rat [8], lacks the secretion signal 
and the laminin-binding NtA domain, but instead has a non-cleaved internal signal sequence, which serves 
as a membrane anchor [19] and turns agrin into a type II transmembrane protein [20]. The amino terminal 
fragment of LN agrin is encoded by three exons, localized 8 kb upstream of the first SN exon. The presence 
 5
Introduction 
of  such a big intron suggests that the two isoforms are transcribed form different promoters, rather than 
being a result of an alternatively spliced common mRNA precursor [21]. 
The expression of the two N-terminal agrin isoforms is highly tissue-specific. The LN agrin is expressed in 
both neural and muscle tissue, while the SN agrin is expressed in nervous system in a variety of different 
neuronal cell types. LN agrin is secreted and integrated into the basal lamina, whereas SN agrin stays 
attached to the plasma membrane [20]. Tissues devoid of the basement membrane, such as brain, 
predominantly express the SN trans-membrane agrin isoform. 
 
II.1.3. Conserved alternative splicing and its functional impact 
 
Additional alternative splicing occurs at two more conserved sites at the C-terminus, in both LN and SN 
agrin: termed A and B in chicken and y and z in rat (Intro, Fig. 1) [22,23]. At the A/y site an alternatively 
spliced exon encodes a four amino acid insert composed of lysine-serine-arginine-lysine (KSRK) which is 
important for heparin binding and modulating the binding to α-DG [24]. The splicing at the B/z site depends 
on the alternative usage of two short exons encoding 8, 11 or 19 (8+11) amino acid inserts. Splicing at both 
sites occurs in a synchronized tissue-specific manner. Agrin isoforms containing inserts at the B/z site 
(denoted as B/z+) are active in clustering of acetycholine receptors at the NMJ and are selectively expressed 
by neuronal tissue [23,25]. Schwann cells are the only non-neuronal cells that express agrin isoforms with 
the B/z+ inserts. 
 
Different combinations of alternatively spliced inserts at the A/y and B/z sites give rise to isoforms with 
significantly different clustering activity [26]. Isoforms A4B8 and A4B19 expressed by motoneurons are the 
most active in AChR clustering, while the A0B0 expressed in muscle are the least active. Recombinant C-
terminal fragment, containing the three lam G domains with A4B8 splicing and total 95kD in size (C95A4B8), 
has very similar activity compared to the full length A4B8 agrin. The fragment containing only the last lam G 
domain, of 21kDa in size, with B8 splicing (C21B8), is sufficient for the clustering activity with several-fold 
lower potency (Intro, Fig. 1) [27]. Alpha-dystroglycan was originally proposed to be the agrin receptor 
involved in AChRs clustering, but the minimal active agrin fragment does not bind to it. Therefore, agrin 
probably binds to another protein, in a manner dependant on the splicing inserts at the B/z site [24].  
 
On the other hand, binding to α-DG is much stronger in isoforms B/z-, lacking inserts at B/z site which 
suggests other physiological roles for this agrin isoform expressed in many non-neuronal tissues, e.g. 
muscle, heart, kidney [23,28]. Binding of agrin to α-DG at the NMJ might provide the structural support and 
stability of the already formed post-synaptic apparatus [24]. Outside the synapse, throughout the muscle 
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sarcolemma, this interaction might contribute to the connection between ECM and intercellular cytoskeleton 
therefore providing better tissue integrity. 
 
II.1.4. Agrin signaling at the neuromuscular junction  
 
At the developing neuromuscular junction (NMJ) the ingrowing nerve and the muscle membrane adopt 
numerous specializations in order to establish a functional contact (Intro, Fig. 2). Proper clustering of 
neurotransmitter receptors is one of the crucial post-synaptic specializations. In the rodent embryo, AChRs 
have a density of about 1000/µm2. In adults, by contrast, AChRs are concentrated at high density up to 
20 000/µm2 in the tiny fraction of synaptic muscle fiber membrane underneath the nerve terminal, whereas 
the remaining membrane (more than 99%) bears less than 10 AChRs/µm2 (for review see [29]).  
 
Fig. 2. Schematic presentation of a vertebrate neuromuscular junction. (Source: http://fig.cox.miami.edu) 
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Since the proposal of the ‘agrin hypothesis’, significant effort has been invested in identifying the receptor 
of agrin and its downstream signaling. A transmembrane receptor tyrosine kinase MuSK (Muscle-specific 
kinase) was considered a likely candidate [30]. Agrin induces rapid phosphorylation of MuSK on wild type 
muscle cells, but on MuSK-/- myotubes it fails to cluster AChRs [31]. Conversely, the AChRs-aggregating 
ability is restored upon MuSK expression [32]. Although agrin and MuSK are functionally correlated, there 
is no direct binding between them, suggesting that MuSK does not serve as a direct agrin receptor, but rather 
as a part of a common signaling complex. MuSK requires additional factors and/or modifications that bind 
and respond to agrin. Moreover, agrin can only activate MuSK in the context of a differentiated myotube, 
Introduction 
and not in immature myoblasts or other cell types, suggesting a necessary role of other signaling factors 
present only in the differentiated muscle cells. Therefore, this putative missing link is termed myotube-
associated specificity component (MASC) [31]. Even without a direct binding to MuSK, a conserved 
tripeptide “asparagine-leucine-isoleucine” within the B8 insert of agrin is necessary and sufficient for the 
full MuSK phosphorylation activity [33]. 
Upon agrin binding to its receptor complex and the concomitant MuSK phosphorylation, downstream 
signaling cascades are activated leading to the activation of rapsyn, a 43 kDa peripheral membrane 
cytoplasmic linker [34-36]. The mobilization of the intracellular rapsyn depends on the extracellular part of 
MuSK, thus their contact is mediated through a putative linker protein which spans the membrane and binds 
the two proteins at opposite sides of the sarcolemma. This hypothetical link is termed rapsyn-associated 
transmembrane linker (RATL) [35]. 
 
Rapsyn binds to AChRs in equimolar ratio and contributes to their clustering, following phosphorylation of 
AChRβ subunits [37]. In vitro experiments with cultured myotubes from rapsyn-deficient mice 
demonstrated that, although MuSK gets phosphorylated and activated, there is no phosphorylation of 
AChRβ subunit and no concomitant AChRs clustering. These data suggested that rapsyn serves as a 
cytoplasmic linker between MuSK activation and the downstream signaling leading to the receptor 
clustering [35]. 
 
Genetic analysis of agrin and MuSK mutant mice supports the importance of the two proteins in forming 
functional NMJs in vivo [38,39]. Agrin mutant mice have significantly reduced number, size, and density of 
AChR clusters on the muscles and they die soon after birth due to breathing failure. The formation of both 
presynaptic and postsynaptic specialization is impaired. Surprisingly, despite the lack of agrin, postsynaptic 
differentiation is present to some degree: small uninnervated AChR clusters distributed over the entire 
muscle fiber and some transcriptional specialization were present in the subsynaptic nuclei [38]. The 
importance of the B/z+ isoform was confirmed in vivo. Agrin knockout mice, with a specific deletion of the 
z exons only, gave the same phenotype as the null mutants [25].  
 
MuSK deficient mice, as the agrin mutants, die at birth due to the inability to breathe. NMJ synapses are 
abnormal, nerve terminals lack arborization and no AChRs are clustered. Muscle structure, on the contrary, 
appears normal in comparison to the wild type control. No specializations are formed either on the 
postsynaptic membrane (AChRs, ErbB4, utrophin, rapsyn) or in the basal lamina (AChE) and the synapse-
specific transcription is abolished [39]. Moreover, muscle cells taken from MuSK-deficient mice fail to 
respond to the neural agrin by clustering AChRs [31].  
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Similarly like agrin and MuSK mutant mice, rapsyn knock-outs do not develop functional NMJs [40]. Their 
motor terminals grow more extensively than those present in wild type mice, but fail to establish synapses 
with clustered AChRs. In rapsyn knock-out mice MuSK is normally localized. This in vivo finding 
supported that agrin activation of MuSK presents the first step in the NMJ development, serving as a 
primary scaffold for docking rapsyn and aggregation of the receptors. 
As a complementary approach to the knock-out studies, ectopic overexpression of agrin confirms its 
orchestrating function at the developing NMJ. Neuronal agrin isoform, when either injected or transfected 
into the extrasynaptyc regions of innervated muscle fibers, can induce postsynaptic specializations and 
AChRs clustering [41,42]. 
 
 
II.1.5. Signaling downstream of MuSK at the NMJ 
 
The agrin-induced signaling downstream of MuSK is still largely unknown. Upon stimulation and activation 
by agrin, MuSK binds the mammalian homologue of the Drosophila melanogaster protein Dishevelled 
(Dvl), a protein involved in the planar cell polarity signaling (Intro, Fig. 3) [43]. At the formed MuSK 
scaffold, protein PAK (p21-activated kinase) is recruited, and gets activated through Rac or Cdc42, thus 
mediating AChRs clustering through the planar cell polarity pathway (PCP). Either inhibition of Dvl or 
PAK interferes with AChR clustering at the neuromuscular synapse.  
 
Fig 3. Signaling at the NMJ downstream of MuSK. Agrin indirectly activates MuSK, it gets phosphoryated 
and recruits Dvl and PAK, further activated by Cdc42/Rac pathway. (Source: www.biocarta.com) 
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Since recently, another cytoplasmic protein, Dok-7, has been implicated in neuromuscular synaptogenesis 
[44]. Dok-7 binds to MuSK through its phosphotyrosine-binding (PTB) domain, induces its 
autophosphorylation, therefore being essential for the activation of the MuSK signaling pathway leading to 
AChRs clustering in myotubes. Mutant mice lacking Dok-7 have the same defects as MuSK and agrin 
mutants, i.e. they are born immobile and die shortly after birth, probably due to the breathing failure.  
Another protein, casein kinase 2 (CK2), binds MuSK in vitro and colocalizes with it at the sites of 
postsynaptic structures in vivo [45]. CK2 mediates phosphorylation of MuSK serine residues within the 
kinase insert domain (KI). In addition, the muscle-specific CK2β knock-out mice develop a myasthenic 
phenotype due to defective NMJ morphology and its impaired function.  
Several distinct proteins, functionally involved downstream of the agrin-MuSK pathway, have been 
identified so far, but the complete signaling pathway has yet to be elucidated. 
 
II.1.6. Dystroglycan and the changes in cytoskeletal organization at the NMJ 
 
As a part of a large transmembrane complex, dystroglycan is recruited to the NMJ where, , it participates in 
the anchoring and recruitment of AChRs during the formation of synaptic as well as non-synaptic AChR 
clusters [46]. Alpha-DG binds agrin and plays a role in AChRs aggregation on muscle myotubes. The same 
blocking antibody, that inhibits receptor aggregation, is able to block agrin binding to α-DG, thereby 
suggesting the importance of their interaction at the NMJ. It is known that binding of agrin to α-DG depends 
on the glycosylation. Accordingly, myotubes with defective glycosylation do not form normal AChRs 
clusters and the binding of α-DG to agrin is abolished [47,48]. Dystroglycan chimeric mice develop 
progressive muscle degeneration and NMJs seem to be disrupted, although the basement membrane 
ultrastructure and laminin deposition look normal [49].  
Based on the agrin-α-DG binding and the aberrant AChRs clustering due to the anti-α-DG blocking 
antibodies, it was expected that α-DG is the functional agrin receptor [47,48]. However, this is not the case 
because α-DG binds equally strongly both active and inactive agrin isoforms [24] and additionally, the 
smallest fragment sufficient to induce AChRs clustering does not bind to α-DG [24,50]. 
At the synapse, dystroglycan colocalises with agrin-induced AChRs clusters and modulates their density, 
but agrin signaling is not significantly changed in muscle cell lines with decreased α-DG level. MuSK 
phosphorylation at later time points does not differ significantly as compared to the normal control. 
Therefore, α-DG is a functional agrin receptor but it is not required for the signaling through MuSK. More 
likely α-DG acts downstream of the AChRs clustering induced by agrin-MuSK signaling to consolodate 
nascent clusters or their maintenance and growth [51]. Although not involved in the initial AChRs clustering, 
dystroglycan and integrins have been implicated in the stabilization of the preformed clusters [52,53].  
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Despite the prominent function of agrin at the NMJ, it is clear that AChRs clusters can spontaneously form 
even in its absence [38]. On the other hand, MuSK and rapsyn are required for these intrinsic postsynaptyc 
patterning events [54,55]. Additionally, transcriptional specialization of synaptic nuclei can occur in the 
absence of innervation. According to more recent interpretation of these data, Agrin/MuSK signaling is 
presumed to stabilize the previously formed AChR clusters and induce their further growth. Following the 
innervation of the pre-formed clusters, the aneural AChR clusters are dispersed by a nerve-dependent 
mechanism [54]. More recent findings suggest that the neurotransmitter ACh acts as a signal for dispersal of 
clustered AChRs, while agrin counteracts it and stabilizes the clusters [56]. In mice lacking ACh, 
neuromuscular junctions can form independently of agrin, meaning that in double mutant mice, synapses do 
form relatively normally. According to this interpretation, agrin is considered to be an AChR clustering 
factor as well as an AChR anti-declustering factor (Intro, Fig. 4).  
 
 
 
 
Fig. 4. Agrin stabilizes the AChR clusters at the NMJ. In Agrin-deficient mice (B) innervation induced 
dispersal of the spontaneously-formed AChRs clusters (A), while in the wild type animals the AChR 
clusters are stabilized (C). (Source: [13]) 
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II.1.7. Functions of agrin outside the NMJ 
 
 II.1.7.1. Agrin and the dystrophin-glycoprotein complex (DGC) in muscle 
 
The dystrophin-glycoprotein complex (DGC) is a large multi-protein complex connecting ECM to the 
intracellular cytoskeleton (Intro, Fig. 5) [57]. The central components of the DGC complex are α- and β-
dystroglycan, post-translationally cleaved from a common precursor protein [58], where α-DG is an 
extracellular peripheral membrane protein that stays non-covalently associated to the transmembrane β-DG. 
Alpha-DG is targeted to the cell surface even in the absence of β-DG, suggesting that the two proteins may 
coordinate independent roles in skeletal muscle signaling [59]. On the extracellular side, α-DG interacts 
with several ECM proteins that contain laminin globular (lamG) domains, e.g. laminin, agrin, perlecan, 
while β-DG on the intracellular side binds to dystrophin which is in contact with the actin cytoskeleton. 
Moreover, β-DG associates with intracellular dystrobrevin and syntrophins at its C terminus, and within the 
membrane it is in direct contact with transmembrane sarcoglycans (α, β, γ, and δ) and sarcospans, 
assembling together a large DGC supramolecular complex (for a review, see [60,61]).  
 
 
Fig. 5. Schematic representation of DGC complex at the muscle membrane outside the NMJ compared to 
the agrin complex at the NMJ. (ECM, extracellular matrix; CM, cell memebrane; CP, cytoplasm; Source 
[61]) 
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Genetic studies on animal models have shown that mutations in many components of the DGC lead 
independently to the outcome of muscular dystrophies. The underlying molecular mechanism is based on 
the interruption of the multi-protein complex between laminin, dystroglycan, and dystrophin which leads to 
the weakening of the connection between ECM and the muscle cytoskeleton (for a review, see [62]). More 
recent findings indicate that, beside the impaired structural integrity, the altered signaling pathways 
contribute to the outcome of muscular dystrophies, namely abnormal Ca2+ influx and defective MAPK 
pathways (for a review, see [63]). 
Glycosylation is crucial for DG binding to its ligands: laminin, neurexin and agrin. DG is abnormally 
glycosylated in several muscular dystrophies what prevents it from establishing functional connections 
necessary for muscle structural integrity. The myodystrophy mouse model (myd) recapitulates the same 
defects in muscle as the patients suffering form muscular dystrophies. In addition, the myd mice display 
brain abnormalities, previously described in the human muscular dystrophy patients. Therefore, the DG-
mediated link between cytoskeleton and ECM is pivotal in the pathology of muscular dystrophy with 
abnormal neuronal migration [64]. 
 
Denervation of muscles in vivo causes changes of muscle membranes and costameres similar to the features 
of muscular dystrophies. On the other hand, the over-expression of secreted B/z- agrin isoform, by 
microinjecting it into an innervated muscle, preserves the organization of muscle structures even after 
denervation [65]. These data imply that agrin has a role in linking the ECM to the cytoskeleton, thus 
providing better structural integrity of the whole muscle membrane. In addition, the over-expression of a 
miniature form of agrin, composed of a laminin-binding NtA domain and lamG domains that bind to α-DG, 
can rescue the dystrophic phenotype of mice carrying mutation in the laminin-2 gene. Agrin is believed to 
make up for the defective link by binding to the other laminins with its N-terminal part and α-DG with its C-
terminus [66]. Therefore, although it is not the only extracellular ligand of dystroglycan, agrin plays a role 
in the DGC complex and the concomitant cytoskeletal dynamics. 
 
 II.1.7.2. Agrin in the central nervous system 
 
In the central nervous system (CNS) agrin is expressed in many cell types, but its function and signaling 
mechanisms are not yet completely clear. The transmembrane (TM) agrin isoform, which lacks the laminin-
binding domain, is the dominant agrin isoform in the brain [19]. Agrin is expressed both by neurons and 
non-neuronal cells in the brain, early in development, and high levels are present in developing brain and 
spinal cord. The isoform lacking the inserts at the z site which has the highest affinity for α-DG is present in 
the blood-brain barrier at the side of the microvasculature. By binding to α-DG, agrin might serve as a link 
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between the ECM and the astrocytic cytoskeleton. Increased permeability of the blood-brain barrier is a 
feature of Alzheimer’s disease, where agrin may be correlated to the disease etiology since it was detected 
as a major component of amyloid plaques and accelerates the fibril formation (reviewed in [67]).  
Agrin was shown to inhibit neurite growth in a variety of neuronal cell types in vitro: in ciliary ganglia (CG) 
neurons, dorsal root ganglia, retina and hippocampus [68-72]. Its expression was detected in, and near, 
multiple axon pathways during development [70], suggesting physiological relevance of agrin function as a 
neurite growth inhibitor. 
 
 In vitro experiments demonstrated that agrin can induce c-fos expression on cultured cortical neurons, as it 
would be expected for a signal transduction pathway activated by a cell surface receptor [73]. Interestingly, 
the alternative splicing does not have any effect on c-fos activation, as compared to the NMJ where it 
influences the clustering activity. Therefore, the in vitro experiments provide evidence for a functional agrin 
receptor in CNS where agrin might have a role in the neuron-neuron synaptogenesis. As expected, the agrin-
defficient neurons are less sensitive to c-fos induction by in vitro experiments. Agrin mutant mice show 
lower mortality and seizure activity in response to kainate, an excitatory drug and a potent agonist of 
glutamate receptors, in comparison to the wild type mice. Additionally, the in vivo induction of c-fos by 
kainate, is much lower in agrin heterozygotes than in wild type mice, suggesting an in vivo role of agrin in 
neuronal signaling by excitatory neurotransmitters [74].  
The attempts to identify the agrin receptor in CNS indicated that agrin binds to several molecules on the 
neuronal surfaces: to αVβ1 integrin, through its second laminin G domain, to β1 integrin with its fourth 
EGF repeat, and with the last laminin G domain to a, yet unidentified, molecule on neuron surface [20].  
 
Colocalization studies on cultured neurons and biochemical binding experiments demonstrated that the CNS 
agrin binds to the Na+/K+-ATPase (NKA) family of membrane ion pumps [75]. Agrin binding evokes fast 
and reversible depolarization of neuronal membrane. The minimum active fragment is the agrin C-terminus, 
of 20 kDa in size, independently of alternative splicing. Interestingly, the sequences flanking the conserved 
alternative splicing site seem to be important, because their deletion, which leaves a fragment of 15kDa, acts 
as an agrin antagonist [76]. Agrin induces similar effects as the cardiac glycoside ouabain, a naturally-
occurring NKA inhibitor, which is used in clinics for the treatment of heart failure and for the in vitro NKA 
inhibition studies. It was demonstrated that the inhibiton of NKA activity is responsible for a form of long-
term plasticity in hippocampal interneurons [77], therefore agrin is speculated to act as an endogenous NKA 
inhibitor involved in synaptic plasticity [75]. 
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II.1.7.3. Functions of agrin in the other organs (i.e. kidney, lung, and immunological system)  
 
The widespread expression of agrin in many adult tissues, e.g. kidney [78,79], lung [12,80], heart, and 
skeletal muscle [23,28], suggests multiple functions outside the developing NMJ. Interestingly, agrin in 
these tissues does not contain the inserts at the conserved B/z site. The agrin isoform A0B0 from several 
tissues (i.e. kidney and lung) binds to α-DG with high affinity. The two proteins were also found co-
localised in the developing organs [80]. This widespread distribution of agrin isoforms which lack the 
AChRs clustering activity, but have the α-DG affinity instead, indicates agrin’s function as a linker between 
basal lamina and the cytoskeleton.  
In kidney agrin was found to be expressed primarily in the glomerular basement membrane [79], where it 
contributes to linking the podocite cytoskeleton to the basement membrane, supporting the membrane 
integrity [81]. In several forms of nephropathy agrin glycosylation is defective, possibly due to increased 
expression of the deglycosylating enzyme heparanase [82].  
 In lung, agrin is expressed in the alveolar basement membranes where it is speculated to inhibit the tissue 
proteases, thus participating in membrane stabilization which has to be tightly balanced with proteolysis 
[12]. 
Agrin plays a role in the formation of the immunological synapse, the functional contact between T 
lymphocytes and antigen presenting cells (APCs), by setting the threshold for T-cell activation and further 
signaling. Agrin is believed to activate T-cells by inducing lipid raft aggregation. Interestingly, T-cells 
express only agrin isoform without alternatively spliced inserts at the z site (z0). In resting T-cells agrin is 
glycosylated, but due to activation it gets extensively deglycosylated, contrary to the activity in the NMJ. 
When incubated with muscle myotubes in vitro, only agrin purified from activated (agrinact) not resting 
(agrinrest) T-cells, was able to induce AChRs clustering despite its lack of inserts at the z site [83]. Agrin is 
expressed on lymphocites and is upregulated in their activation. Alpha-DG is also expressed on 
lymphocytes and collocalises with agrin. Down-regulation of α-DG expression inhibits lymphocyte 
activation even in the presence of agrin, suggesting that both factors together mediate lymphocyte activation 
[84]. 
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II.2. Caenorhabditis elegans – more than just a worm 
 
II.2.1. C. elegans as a biological model organism 
 
C. elegans is a free-living nematode with the natural habitat in the soil. Its body is approximately 1mm long 
and 0.1mm wide. It is built of various types of cells, with an invariable number of 959 cells in 
hermaphrodites and 1031 cells in males [85]. The relatively simple anatomy, fast generation time (3 days at 
25˚C), large number of progeny (300 – 350 from a single parent), and easy maintenance in the laboratory 
make it a very attractive model organism. Sydney Brenner was the one who recognized the potential of C. 
elegans for powerful genetics and in 1965 pioneered studies of it in the laboratory [86]. The worms’ 
transparent body made it possible to dissect developmental lineages for each cell in the developing worm 
[87]. 
 
 
Fig 6. Anatomy of an adult hermaphrodite (Source: www.wormatlas.com). A, DIC image of an adult 
hermaphrodite, as seen from left lateral side. Scale bar 0.1 mm. B. Schematic drawing of anatomical 
structures, left lateral side. Dotted lines and numbers mark the level of transverse sections from the figure 
source (not shown here). 
Although quite simple, the organs in C. elegans are highly sophisticated and therefore of interest to be 
studied (Intro, Fig. 6). They include a gastrointestinal tract, a reproductive system, epithelial, nervous, 
muscle, excretory tissues, and immune system. In addition, most of the underlying molecular mechanisms 
for the major physiological processes are highly conserved when compared to vertebrates [88]. Therefore, 
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the experimental data obtained from the worm proved to be highly informative and applicable in elucidating 
the analogous mechanisms in mammals.  
Different genetic approaches have been taken to investigate the functions of the vertebrate gene homologues 
identified in C. elegans genome (reverse genetics) or to identify the previously unknown genes which, if 
mutated in the worm, result in interesting phenotypes (forward genetics). For forward genetics, worms are 
commonly mutated with chemical mutagens (such as ethyl methane sulphonate, EMS) often in combination 
with UV irradiation [86,89], followed by large-scale screens to identify certain phenotypes, such as 
resistance to a particular drug (e.g. levamisole, aldicarb, ivermectin). On the other hand, in reverse genetics 
approaches. The goal is to learn more about a particular, already known, gene and address its mechanisms of 
action in C. elegans [90]. Both approaches are commonly used to identify novel candidate drug targets for 
treatment of human diseases (reviewed in [91]). 
As mentioned above, there are two C. elegans sexes, a self-fertilizing hermaphrodite (XX) and a male (XO). 
In a normal population males arise infrequently (0.1%), but through mating they occur at higher frequency 
(up to 50%). Hermaphrodites can be induced to generate male progeny spontaneously at a higher rate by 
treatment at 30˚C. Hermaphrodite self-fertilization allows the generation of genetically identical progeny 
from homozygous mutants, while mating facilitates the isolation and maintenance of mutant strains as well 
as moving mutations between strains. 
 
 
II.2.2. Anatomy of the adult neuromuscular-related systems 
 
II.2.2.1. Nervous system 
 
In adult C. elegans hermaphrodites there are 302 neurons and 56 neuron-related glial cells, together making 
up for 37% of the total somatic cell number in the adult hermaphrodite (reviewed in [92]). Since many of 
the neurons are not essential for the animals’ survival in laboratory conditions, even mutations causing 
severe impairments can still be maintained and experimentally studied, a fact that makes C. elegans a 
wonderful model for neurobiology. 
The neurons in C. elegans can be classified by at least four different criteria: general function (sensory, 
interneurons, and motoneurons); “neurotransmitter phenotype” (GABAergic, glutamatergic, cholinergic); 
according to the functional units (e.g. sensory sensilla); based on the specific morphological features (cell 
body position, axodendritic morphology, synaptic connectivity) (Intro, Fig. 7). Unlike in most species, in C. 
elegans a well defined neuronal precursor does not exist, therefore even the cells within the same class 
(according to the classifications above) do not originate from the same lineage.  
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Remarkable work on the reconstructions of serial electron microscopic sections form the whole C. elegans 
body provided significant insight into the anatomy of its nervous system and helped define 118 main neuron 
classes according to morphological criteria [93]. Sensory neurons and interneurons occur mostly in 
bilaterally symmetric pairs. The entire nervous system has in total 5000 chemical synapses, 600 gap 
junctions and 2000 neuromuscular junctions [94].  
 
 
 
 
 
 
Fig 7. The structure of the C. elegans nervous system with depicted positions of the main ganglia and 
process bundles (only the left side of the bilaterally symmetrical neurons presented). Neuronal processes run 
along the body mainly in the ventral and dorsal cord (connected by commissural processes) and along lateral 
axonal tracts. (source: [95]) 
 
Sensory neurons have openings at the cuticle with specialized sensory endings (e.g. ASH amphid neurons). 
The chemosensory neurons can be classified as follows: two bilaterally symmetrical amphids each 
containing endings of 12 sensory neurons; two symmetric phasmids in the tail, each consisting of two 
neurons; and six inner labial (IL) sensory organs in the head [96].   
There are several classes of mechanosensory neurons based on the stimuli they are specialized for and the 
responses they induce. The ASH, FLP and OLQ neurons are responsible for the light nose touch, each class 
accounting for a fraction of the normal response. In addition, ASH neurons have a unique polymodal role in 
sensing high osmolarity and volatile repellents [97]. Glutamatergic neurons IL1 and OLQ synapse to the 
RMD neuron and are responsible for spontaneous foraging (i.e. head movements) and head withdrawal 
reflex [98]. Touch cells ALM, AVM, PLM are responsible for sensing light body touch, experimentally 
scored by an eyelash touch along the body. Those cells respond also to gentle tapping sensation [99]. The 
worms can distinguish between light and harsh body touch because different neurons are stimulated. The 
harsh touch stimulates PVD neurons which synapse to the AVA and PVC interneurons, experimentally 
scored by a thin platinum wire. 
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In order to evoke movement, a sensory input is transmitted to the motoneurons, either directly or through 
the interneurons. Most of the synapses are localized at the nerve ring, a neuropile around the pharynx. The 
motoneurons and interneurons in C. elegans extend their axons mainly along the dorsal and ventral midline 
of the body, in the fasciculated tracts of the dorsal and ventral nerve cord. Their cell bodies are localized in 
one of the ganglia (Intro, Fig. 7) or along the ventral nerve cord, from where they can extend circumferential 
processes, commissures, towards the dorsal cord. Many different molecules are implicated in the axon 
guidance along the ventral midline (e.g. netrin/UNC-6 via the attractant DCC/UNC-40 receptor, EphR/VAB 
-1, collagen XVIII, nidogen) and the commissural guidance towards the dorsal cord (e.g. UNC-6/netrin via a 
repulsive UNC-5 receptor). The mutations of two heparan sulphate-modifying enzymes were identified in 
genetic screens as responsible for defects in axon branching, therefore indicating the importance of 
glycosylation in axon guidance (reviewed in [100]). A recent report provided evidence that the heparan 
sulphate syndecan (SDN-1) regulates cell migration and axon guidance in C. elegans [101]. 
 
 
II.2.2.2. Muscle system   
 
In C. elegans there are several groups of muscles with different structure and function, namely two major 
groups: striated body-wall muscles, supporting locomotion, and non-striated muscles such as pharyngeal, 
intestinal, vulval, uterine and anal muscles [102]. Sarcomeres are the main structural components of all 
muscles: striated muscles contain many highly-organized sarcomeres, while non-striated ones have only one.  
 
In the body-wall muscles of C. elegans, sarcomere assembly is a highly orchestrated process, giving rise to 
the sarcolemma attachments with remarkable similarity to vertebrates [103]. The body wall muscles are 
positioned longitudinally, assembled from 95 cells organized in four quadrants (two dorsally, two ventrally) 
each consisting of two rows of muscle cells in staggered pairs (Intro, Fig. 8A,B). Each spindle-shaped 
muscle cell makes attachment complexes to the neighboring muscle cells as muscle-muscle plaques, as well 
as attachments to the hypodermis. Additional strong attachments are established between muscles and 
hypodermis, through the basal lamina, particularly through the contact between integrin (PAT-2/PAT-3) and 
perlecan (UNC-52). Within the muscle cells, precisely aligned with the hypodermal contacts, dense bodies 
and M-lines are positioned and attached to the actin thin filaments and myosin thick fibers (Intro, Fig. 8C). 
On the side towards hypodermis, hemidesmosome-like structures make connections the cuticular 
exoskeleton [104]. In the regions of muscle contacts, the hypodermis contains tightly compressed structures 
rich in organized intermediate filaments (IFs) called fibrous organelles [105]. MUA-3 is one of the proteins 
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implicated in these attachments localized on the apical side of the hypodermis [106]. Their development is 
tightly coordinated with the muscle development, and regulated by several factors, such as myotactin [107]. 
 
 
Fig 8. Schematic diagram of the C. elegans body-wall muscle structure. A, Worm seen from the front, 
muscle bundles are shown in orange. B, Cross-section through the body wall. C, Enlarged segment of the 
body-wall and the muscle attachments to the hypodermis. (Source: [103]) 
 
The nonstriated muscles, such as the pharyngeal muscles, contain a single sarcomere, with the attachment 
points localized at the end of a cell, connecting myofilaments to the epithelium or basal lamina. 
 
 
II.2.2.3. Neuromuscular junctions in C. elegans – development & anatomy  
 
Neuromuscular junctions are specialized chemical synapses between presynaptic motoneurons and 
postsynaptic muscles. There is a significant insight into the development and structure of C. elegans NMJs, 
mainly due to their physical accessibility and excellent possibilities for genetic analysis.  
 
Muscles in C. elegans have a unique property to make specialized cell projections, called muscle arms, 
which extend from the muscle bundles and reach the proximal nerve cord (Intro, Fig. 9) [92,100]. Since in C. 
elegans the motoneurons and the body-wall muscles are separated by a basement membrane, the muscles 
have to pass through it and make direct contact to the motoneuron axon [93]. On the sites of contact, the 
muscle arms make en passant synapses to the motor axons that run along the anterioposterior axis. 
Depending on the type of the neurotransmitter, the NMJ synapses can be excitatory (cholinergic with ACh) 
or inhibitory (GABAergic). 
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Fig 9. Transverse cut through the mid-body of C. elegans. A, Schematic view of the ventral and dorsal 
muscle bundles (yellow and brown), touching the nerve cords through the muscle arm extensions. Rectangle 
labels the regions enlarged in B. Ventral (VHR), dorsal (DHR) and lateral (LHR) hypodermal ridges are 
pointed with red arrows. The right axon bundle of the ventral nerve cord and the left bundle of the dorsal 
cord are shown in blue. B, A false-colored transmission electron micrograph of the transverse section of the 
ventral midline. The muscles are shaded in pink and separated from the nerves by basal lamina, except in 
the point of NMJ contacts. (Sources: [108,109]) 
 
 
Genetic screens for synaptogenesis mutants have identified key players in NMJ formation and structure. 
Animals carrying mutations at the synaptic components often exhibit uncoordinated movements (unc), egg-
laying defects (egl), defecation defects or paralysis. Pharmacological assays with nematocidal drugs, such as 
cholinergic agonist levamisole or the acetylcholine esterase inhibitor aldicarb, have been extensively used in 
screening for mutants (Intro, Fig. 10) [86]. The drugs which are toxic for the wild type worms cause 
resistance in the synaptic mutants. The genes for several postsynaptic AChR subunits were identified on the 
basis of their resistance to levamisole, e.g. unc-29, unc-38, unc-63, lev-1 [86,110]. Altogether, at least 16 
nAChR subunit genes are thought to be expressed in C. elegans [111]. 
Neuromuscular junctions in C. elegans are highly dynamic structures. Several proteins have been identified 
as crucial factors for the normal NMJ development. One of them is a transmembrane protein LEV-10. The 
mutant was identified as weakly resistant to levamisole due to significantly reduced postsynaptic density of 
AChRs [112]. Interestingly, the LEV-10 extracellular protein domain alone is sufficient to rescue the lev-10 
mutant phenotype, suggesting a novel AChRs clustering mechanism. 
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Fig 10. Schematic diagram of the levamisole mechanism at the nematode NMJ. In the wild type worms, 
where AChRs are clustered normally, the drug binds irreversibly and causes toxicity. In the mutant worms, 
with defective AChR clusters, the agonist effect is sub-toxic and the animals appear resistant. 
 
In vertebrates one of the key factors involved in AChR clustering is the receptor tyrosine kinase MuSK. The 
gene with the highest similarity to MuSK in C. elegans is an orphan receptor KIN-8 (CAM-1) [113,114]. In 
addition to the impairment in cell polarity and neuron migration, the kin-8/cam-1 mutants are uncoordinated 
and have mislocated AChR subunit ACR-16 [115]. Therefore, kin-8/cam-1 in C. elegans might be a protein 
with a similar role as MuSK in vertebrates. 
Synaptic ECM proteins have been implicated in NMJ formation in the worm, namely collagen XVIII (CLE-
1) and nidogen (NID-1) [116]. Single mutants in each of the genes generally cause reduced number of the 
enlarged and diffuse GABA receptor clusters.  
Agrin, which is the main postsynaptic organizer at the vertebrate NMJ, has been identified in the C. elegans 
genome [117], but has not been further investigated. 
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II.2.3. Pharynx 
 
The pharynx is an alimentary muscle organ with its own nervous system, gland cells, and structural cells 
surrounded by a basal lamina. Its precise structure was identified from serial electron micrographs that 
revealed its main components: 20 syncytial muscle cells, 9 marginal, 9 epithelial, 5 gland cells and 20 
neurons [118]. The pharynx starts at the anterior part of the worm’s body with the buccal cavity (mouth), 
followed by the procorpus, the anterior bulb (metacorpus), a narrower part called isthmus that ends with the 
terminal bulb which contains the grinder for crushing bacterial food (Intro, Fig. 11) (reviewed in [119]).  
 
 
Fig 11. DIC image of the C. elegans pharynx. All the major segments are labeled in black and the interior 
cuticular structures in yellow. (source: www.wormatlas.org) 
 
Pharyngeal muscles are organized in eight segments (pm1-pm8) forming consecutive rings that radially 
encircle its lumen. Most of the pharyngeal muscle rings are composed of three muscle cells giving rise to a 
three-fold symmetry (see Fig 15, Unpublished results). The majority of the muscle cells are separated by 
marginal cells, epithelial cells rich in the intermediate filaments that provide structural integrity to the entire 
pharynx.  
Of the 20 neurons innervating the pharynx, five are motoneurons (M1-M5), six are interneurons (I1-I6), and 
the others are neurosecretory motoneurons (NSMs), marginal cell neurons (MCs) and a motor-interneuron 
(MI) [118]. Most of their cell bodies localize to one of the pharyngeal bulbs, sending processes to the 
anterior and /or posterior part. The motoneurons make NMJs directly to the pharyngeal muscles, while the 
others synapse to each other, either within a small local plexus or “en passant”. Since the pharynx is 
surrounded by its own basement membrane, the only link with the somatic nervous system is through a pair 
of RIP neurons that receive input from extrapharyngeal IL1, IL2, URA, and RME (reviewed in [119]). 
 
The pharynx is specialized to pump and concentrate food (bacteria suspended in liquid) before grinding it 
within the grinder of the posterior bulb and pushing it further into the gut [120]. Its complex movements 
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involve highly coordinated isthmus peristalsis and the contractions (pumping) of the posterior bulb. The 
pharynx of a wild type worm pumps at the rate of about 4 pumps/second in the presence of food and 1 
pump/second in its absence [121]. Many mutations, that have been discovered so far, cause reduced 
pharyngeal pumping rate or defects in the coordination of pharyngeal movements [122]. Based on the 
phenotype, the mutants are called eat, and their underlying mutations affect different proteins involved in 
pharyngeal function, e.g. eat-2 and eat-18 code for the nicotinic AChRs subunits [123], eat-4 for a sodium-
dependent inorganic phosphate transporter [124], and eat-5 is related to the connexin family involved in the 
cell-cell interactions [125], etc. The size of the food particles (bacteria) influences edibility and regulates 
subsequently the worms’ growth rate [120]. Larger bacterial strains, such as Bacillus megaterium, are 
generally less well tolerated and wild type worms grow more slowly when fed on them.  
 
 
II.2.4. Basement membranes 
 
Basement membranes (BMs), specialized thin layers of extracellular matrix (ECM) in C. elegans have been 
extensively studied giving rise to substantial insight in the major components and functions (for a review, 
see [126]). In addition to supporting structural integrity, BMs provide the scaffold for signaling molecules. 
In C. elegans, BMs cover the surfaces of all internal tissues and surround the pharynx, body wall muscles, 
intestine, gonad, and hypodermis on the pseudocoelomic side. 
Most of the key proteins essential for the assembly of the BMs are conserved between the nematode and 
vertebrates [117]: laminin, perlecan, collagen IV, osteonectin/SPARC, and collagen XVIII and nidogen, 
involved in the organization of the nervous system. Almost all of those proteins play a certain role in gonad 
development. As expected, the gene families for the ECM genes are generally smaller in C. elegans, making 
it easier for the experimental set-up. Different BM proteins are expressed in a different spatio-temporal 
manner and often regulated on the level of alternative splicing.  
 
Laminins are heterotrimeric glycosylated proteins comprised of an α, β, and γ chain, which in different 
combinations result in more than 15 isoforms in vertebrates. In C. elegans there are two α (αA LAM-3 and 
αB EPI-1) only one β (LAM-1) and γ (LAM-2) chain, giving rise to two laminin isoforms. They have 
distinct localization patterns with some overlap [127]. Putative null mutation of the αB chain, epi-1(rh199) 
causes embryonic and larval arrest in more than two thirds of the population and sterility in almost one third 
[128]. In addition, the epi-1 mutation has been implicated in neuron migration [129]. Mutant animals in the 
αA chain, lam-3(n2561) arrest as embryos or L1 larvae [127]. Since LAM-3 is dominantly expressed in the 
pharynx, the pharyngeal BMs display obvious defects. 
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The perlecan ortholog in C. elegans is encoded by the unc-52 gene and its protein product can be detected 
exclusively in the BMs surrounding muscle cells [130]. Complex alternative splicing of a common 
transcript gives rise to several isoforms [131]. The most severe phenotypes caused by unc-52 mutations 
result in Pat phenotype (paralysis at the two-fold stage) due to defects in muscle development. Mutations in 
some of the components necessary for RNA splicing cause a synthetic lethal phenotype together with unc-
52, confirming the importance of this tightly-regulated process. Viable unc-52 alleles display defects in the 
migration of the distal tip cell of the gonad in a cross-talk with the netrin/UNC-6 system [132].  
 
In vertebrates two nidogen/entactin genes encode ubiquitous glycoproteins consisting of two globular 
domains spaced from the third by a rod domain mainly composed of EGF repeats. In C. elegans there is 
only one gene nid-1, with three alternatively spliced variants [133]. NID-1 is primarily concentrated in the 
nerve ring and the BM of the gonad, but it is not essential for the BM assembly, since all mutants are viable 
and fertile. NID-1 is closely associated with NMJ synapses and was shown to affect synaptic organization 
together with collagen XVIII [116].   
 
Collagen XVIII exists in C. elegans as a single orthologue cle-1, which is highly conserved at its C-terminus 
to the vertebrate protein. The usage of different promoters and alternative splicing give rise to at least three 
major isoforms. CLE-1 localizes primarily to the nervous system where it has been implicated in synaptic 
organization and function [116]. 
 
Collagen IV is the most abundant BM protein, highly conserved among species, form sponges to humans. 
Two genes that encode collagen IV have been identified and characterized in C. elegans, emb-9 and let-2 
[134]. Multiple mutant alleles for both genes cause embryonic lethality, demonstrating that normal collagen 
IV is necessary for embryogenesis.  
 
Integrins are transmembrane α/β heterodimers that bind to many components of ECM and serve as the ECM 
receptors, involved in cell migration, matrix assembly and remodeling. In vertebrates there are at least 20 
distinct integrins, but in C. elegans only two are predicted, assembled form the proteins encoded by two α 
(ina-1 and pat-2) and one β (pat-3) genes [135,136]. INA-1 is the most similar to the laminin-binding 
integrins and PAT-2 to the RGD-binding integrins of vertebrates. Both genes are broadly expressed, but ina-
1 becomes restricted to some tissues at the L1 larval stage. Strong alleles for ina-1 cause lethality while 
weaker ones have mispositoned neurons and defasciculated axonal tracts suggesting  defects in adhesion 
between axons [135]. The pat-2 and pat-3 mutants got their name after the Pat phenotype (paralysis at the 
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two-fold stage) because they fail to form normal muscle structures [136], similarly like unc-52 perlecan 
mutants [130]. Therefore, this integrin was suggested to bind perlecan as its transmembane receptor. 
 
Several other BM / ECM components have been identified and characterized in C. elegans, such as: 
SPARC/osteonectin (ost-1, [137]) an essential protein restricted to body wall and sex muscles; fibulin (fbl-1 
[138] that binds to laminin and nidogen and its loss can suppress the mutations in ADAM-like genes; and 
hemicentin (him-4, [139]) which, when mutated, causes defects in adhesion. 
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II.3. Aim of the work 
 
The work presented in this thesis was done with the primary goal to confirm experimentally the existence of 
an agrin orthologue in C. elegans, to characterize its expression pattern and to elucidate its function. Since 
in vertebrates the mechanistic link between agrin and MuSK is still unclear together with the downstream 
signaling at the NMJ, we intended to lay the basis for the identification of the missing links by taking 
various genetic and biochemical approaches. We investigated putative agrin interacting factors in search for 
conserved and/or novel molecules that could help us add another small building block to the understanding 
of the extracellular matrix organization.  
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III. Results 
 
III.1. Submitted manuscript 
 
 
 
C. elegans agrin is expressed in the pharynx, IL1 head neurons and the distal tip cells 
of the gonad and it does not genetically interact with genes important for 
synaptogenesis or muscle function. 
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Abstract 
Agrin is a basement membrane protein crucial for development and maintenance of the neuromuscular 
junction in vertebrates. The C. elegans genome harbors a putative agrin gene agr-1. We have cloned the 
corresponding cDNA, to determine the primary structure of the protein, and expressed its recombinant 
fragments to raise specific antibodies. The domain organization of AGR-1 is very similar to the vertebrate 
orthologues. It contains a signal sequence for secretion, seven follistatin domains, three EGF-like repeats 
and two laminin G domains. AGR-1 null mutants did not exhibit any overt phenotypes and did not acquire 
resistance to the acetylcholine receptor agonist levamisole. Furthermore, crossing them with various mutants 
for components of the dystrophin-glycoprotein complex, that have impaired muscle function, did not lead to 
an aggravation of the phenotypes. Promoter-GFP translational fusions, as well as immunostaining of worms, 
revealed expression of agrin in buccal epithelium and the protein deposition in the basal lamina of the 
pharynx. Furthermore, dorsal and ventral IL1 head neurons and the distal tip cells of the gonad arms are 
sources of agrin production, but no expression was detectable in body muscles or the motoneurons 
innervating them. Recombinant worm AGR-1 fragment is able to cluster vertebrate dystroglycan in cultured 
cells, implying a conservation of this interaction, but since neither of these proteins is expressed in muscle 
of C. elegans, this interaction may be required in different tissues. The connections between muscle cells 
and the basement membrane, as well as neuromuscular junctions, are structurally distinct between 
vertebrates and nematodes.  
 
 
 
Key words: Agrin, basement membrane, pharynx, neuromuscular junction, Caenorhabditis elegans 
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Introduction 
Agrin is a large proteoglycan with a prominent function at the developing neuromuscular junction (NMJ) 
where it plays a pivotal role in the formation and maintenance of the acetylcholine receptor (AChR) clusters. 
Agrin was discovered more than two decades ago through the observation that trophic factors from the basal 
lamina extract of electric ray (Torpedo californica) were able to induce AChRs clustering on muscles in 
vitro [1]. The protein was subsequently purified from the extract of the synapse rich Torpedo electric organ 
and, based on the observed aggregating activity, was named “agrin”, coming from Greek “ageirein” which 
means “to assemble” [2]. Further studies revealed that agrin is synthesized by motor neurons that release it 
into the synaptic cleft where it stably integrates into the synaptic basal lamina (BL), a specialized thin layer 
of the extracellular matrix (ECM) [3-5]. Based on these findings, McMahan proposed the ‘agrin hypothesis’, 
which states that agrin is a nerve-derived synaptic organizing molecule [6], (reviewed in [13,140]).  
Agrin has been cloned from several vertebrate species including rat [8], chick [9,10], marine ray (Torpedo 
californica) [11], and man [12]. All described agrin gene orthologues encode a large protein of more than 
2000 amino acids with an approximate molecular weight of 225 kD. Additional O-linked glycosylation by 
heparan and chondroitin sulphate glycosaminoglycan chains together with N-linked carbohydrates  raise the 
molecular weight up to 400-600 kDa [14,15], reviewed in [13]. The domain architecture of agrin is 
characterized by several repeated structural motifs which share homology with follistatin (Kazal-type 
protease inhibitors), laminin epidermal growth factor (EGF) and laminin globular (lamG) domains. In 
addition the protein contains a SEA module common between sea urchin sperm protein, enterokinase and 
agrin flanked by serine/threonine (S/T)-rich regions [8,9]. Differential transcription of the first exon results 
in a longer form which is secreted and binds to the basal lamina via its laminin-binding N-terminal agrin 
(NtA) domain [10,17,18] and a shorter isoform which lacks the NtA domain and remains in the membrane 
as a type II transmembrane protein [19,20]. Additional alternative splicing, in a tissue-specific manner at 
two conserved sites, termed A and B in chicken or y and z in the rat, respectively, gives rise to isoforms 
with significantly different activities in clustering AChRs [23,24,26]. Isoforms expressed by motoneurons, 
which contain inserts at the B/z splice site, are active in AChR clustering, whereas agrin expressed by 
muscle, lacks the inserts and does not cluster AChRs.  
Despite of numerous studies available, the mechanism of agrin action has not been completely solved yet. 
Muscle specific kinase (MuSK) is a transmembrane receptor tyrosine kinase necessary for agrin-induced 
AChR clustering without direct interaction with agrin. The missing link in this signaling pathway is a 
hypothetical protein termed MASC (myotube-associated specificity component) able to mediate the 
interaction between agrin and MuSK [31,38]. Genetic analysis of agrin and MuSK deficient mice support 
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the common function in AChRs clustering [38,39]. Both mutants die at birth due to breathing failure. Agrin 
null mutants and mice lacking only B/z+ agrin exons have a significantly reduced number, size, and density 
of AChRs clusters on the muscle, although, some postsynaptic differentiation is present [25,38]. In MuSK 
mutant mice, NMJ synapses and the related specializations can neither be found on the postsynaptic 
membrane nor the basal lamina [39]. Signaling downstream of MuSK is still largely unknown. Several 
reports demonstrated MuSK-related activation of different proteins, leading to AChRs clustering. Among 
them were dishevelled (Dvl), a protein involved in planar cell polarity signaling [43], a cytoplasmic protein 
Dok-7 [44], and protein casein kinase 2 (CK2) [45], essential for NMJ synaptogenesis in vitro and in vivo.   
In addition to the NMJ, many non-neuronal tissues, such as muscle, heart and kidney, express an agrin 
isoform without inserts at the B/z site [23,28]. Alpha-dystroglycan (α-DG) binds to this alternative splice 
variant in different tissues with strong affinity, by a carbohydrate-dependent mechanism [47,80]. In 
vertebrates, muscle dystroglycan is a central component of a large dystrophin-glycoprotein complex (DGC) 
connecting the ECM with the intracellular cytoskeleton (reviewed in [60,141]). Genetic studies on animal 
models have shown that mutations in many components of the DGC independently lead to the outcome of 
muscular dystrophies (reviewed in [62-64]). Agrin binding to α-DG might contribute to the connection 
between the ECM and the cytoskeleton thus improving tissue integrity [65]. The interaction between agrin 
and α-DG is functionally conserved in the formation of the immunological synapse between antigen 
presenting cells (APC) and T-cells [83,84]. 
 
The nematode C. elegans is a useful model organism with many experimental advantages, e.g. short 
generation time, easy maintenance, transparent body, simple but specialized organs which make it a 
powerful tool for genetic analysis [86,88]. C. elegans harbors a gastrointestinal tract, a reproductive system, 
epithelial, nervous, muscle, excretory cells, and even innate immunity pathways [142]. In addition, most of 
the molecular mechanisms underlying major physiological processes are highly conserved when compared 
to vertebrates [88]. Therefore, the experimental data obtained from the worm proved to be highly 
informative and applicable in elucidating many analogous mechanisms in mammals, for a review, see [143]. 
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NMJs in C. elegans have some distinct morphological features when compared to the vertebrate 
counterparts. Instead of motoneurons growing axons towards the muscles they innervate, muscles in C. 
elegans make specialized cell projections, called muscle arms, which extend from the muscle bundles to 
reach the proximal nerve cord [92,100]. At the sites of contact, the muscle arms make en passant synapses 
to the motor axons that run along the anterioposterior axis. Depending on the type of the neurotransmitter, 
the NMJ synapses can be excitatory (cholinergic) or inhibitory (GABAergic). Genetic screens for 
synaptogenesis mutants have identified key players in NMJ formation and structure. Animals carrying 
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mutations in synaptic components often exhibit uncoordinated (unc), egg-laying defects (egl), defecation 
defects or paralysis. Pharmacological assays with nematocidal drugs, such as the cholinergic agonist 
levamisole or the acetylcholine esterase inhibitor aldicarb, have been extensively used in screening for 
mutants that are resistant to these drugs [86]. The genes for several postsynaptic AChR subunits were 
identified on the basis of the resistance to levamisole, e.g. unc-29, unc-38, unc-63, lev-1 [86,110]. 
Neuromuscular junctions in C. elegans are highly dynamic structures. Several proteins have been identified 
as crucial factors for normal NMJ development. One of them is a transmembrane protein LEV-10. The 
mutant was identified as weakly resistant to levamisole due to significantly reduced postsynaptic density of 
AChRs [112]. Interestingly, the LEV-10 extracellular protein domain alone is sufficient to rescue the lev-10 
mutant phenotype, suggesting a novel AChRs clustering mechanism. 
 
In vertebrates one of the key factors involved in AChR clustering is the receptor tyrosine kinase MuSK. The 
gene with the highest similarity to MuSK in C. elegans is an orphan receptor KIN-8 (CAM-1) [113,114]. In 
addition to the impairment in cell polarity and neuron migration, the kin-8/cam-1 mutants are uncoordinated 
and have mislocated AChR subunit ACR-16 [115]. Therefore, KIN-8/CAM-1 in C. elegans might be a 
protein with similar role as MuSK in vertebrates. Several other synaptic ECM proteins have been implicated 
in the NMJ formation in the worm, namely collagen XVIII (CLE-1) and nidogen (NID-1) [116]. Single 
mutants in each of the genes causes reduced numbers of the enlarged and diffuse postsynaptic receptor 
clusters.  
Different genetic approaches have been taken to investigate the functions of the vertebrate gene homologues 
identified in the C. elegans genome (reverse genetics) or to identify the previously unknown genes which, if 
mutated in the worm, result in interesting phenotypes (forward genetics). In reverse genetic approaches, the 
goal is to learn more about a particular gene of interest and address its mechanisms of action in C. elegans 
[90]. Since in C. elegans and C. briggsae, two closely related nematode worm species, putative agrin 
orthologues have been identified on the basis of genomic sequence analysis [117], we decided to take a 
reverse genetics approach to clone the C. elegans agrin cDNA, characterize the protein, and describe its 
expression pattern. We found expression of agrin in four head neurons, the distal tip cell of the gonad, and 
in epithelial cells of the pharynx. We could not detect any agrin in muscle or at NMJs and genetic analysis 
of agrin mutants did not provide any evidence for a major function of agrin in AChR clustering or muscle 
function in the worm. However, the known binding of agrin to α-DG in vertebrates, seems to be conserved 
by C. elegans agrin, pointing to an ancestral role of this interaction.  
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Results 
 
C. elegans expresses an agrin-like gene agr-1 
 
A nematode agrin gene, with sequence homology to vertebrate agrin, was identified in the C. elegans 
genome. The analysis was based on queries by BLAST searches of Wormpep followed by reciprocal 
BLAST searches of insect or mammalian orthologs in GenBank [117]. In WormBase, the online database of 
the C. elegans genome, the agrin gene was mapped to the cosmid F41G3, originally as two separate open 
reading frames (ORFs) named F41G3.12 and F41G3.15, one corresponding to the 5’ and the other to the 3’ 
part of vertebrate agrin, respectively. Based on the predicted gene sequences, the agrin-specific primers 
(Table 1; Fig.1) were used to amplify overlapping fragments of each of the predicted ORFs and of a putative 
common transcript from cDNA reverse transcribed from RNA isolated from mixed stages of worms. As a 
result, three overlapping fragments gave rise to one unique agrin sequence instead of the two ORFs 
predicted by WormBase. The incorrect prediction was probably due to three sequence mistakes present in 
WormBase which resulted in false stop codons. The additional bases identified in our cDNAs are 
highlighted with red rectangles in Fig.1 and their positions in the genome are indicated by black arrows in 
Fig.2. The identified agr-1 coding region is 4422 bp long with 5’ and 3’ untranslated regions of 212 and 160 
bp, respectively (Fig. 1). The agrin ORF is encoded by 29 exons which span a chromosomal region of 
almost 14.5 kb (Fig. 2). The gene harbors two very big introns, one following exon 4 and the other 
following exon 24, but no alternative splicing was found. We attempted to identify putative alternative 
exons corresponding to the B+/z+ splicing described in vertebrates [23,26] by PCR with primers on 
neighboring exons, but could not detect any differential splice variants.  
 
 
AGR-1 protein domain architecture is similar but not identical to its vertebrate homologues  
 
The predicted agrin protein AGR-1 sequence consists of 1474 amino acids (Fig. 1). Domains were predicted 
by computational analysis of this protein sequence using the SMART bioinformatics tool package (Fig. 3) 
[144]. A putative 22 amino acids-long signal sequence (purple) is followed by seven Follistatin domains (F, 
blue), two epidermal growth factor domains of the laminin-type (LE, gray), another follistatin domain (F, 
blue), an epidermal growth factor (EGF)-like domain (EG, orange) and two laminin G domains (LamG, 
yellow).  
When compared to the known vertebrate agrin orthologues, the C. elegans protein shares a high similarity in 
terms of modular architecture, but is missing certain domains (Fig. 3). Vertebrate agrin molecules exist in 
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two different forms, one with a signal sequence followed by a laminin-binding NtA domain (Fig. 3, light 
purple) and another one with a non-cleaved signal sequence (TM, empty rectangle) serving as a 
transmembrane anchor [10,19]. Using a 5’ RACE approach in C. elegans only one isoform was found, 
containing a signal sequence, but no laminin-binding NtA domain. The signal sequence, together with a 
corresponding cleavage site between the amino acids 22 and 23, was predicted with 0.74 probability by 
Signal P3.0 Server [145]. However, we could not find any potential exon encoding a domain similar to the 
NtA domain in the genomic sequence. The N-terminal part of AGR-1 has seven repetitive follistatin 
domains, while vertebrate agrin contains eight of them. Further differences are present in the C-terminal part 
of the AGR-1 protein where the serine/theonine-rich regions (S/T, light yellow) are missing as well as the 
SEA (sea urchin sperm protein, enterokinase, agrin) domain. Vertebrate agrin is a heavily glycosylated 
protein, carrying large O-linked heparan sulphate and chondroitin sulphate chains at several positions in the 
protein [14,15] shown as branched structures in Fig. 3. This is probably not the case for AGR-1 since the 
S/T-rich region is missing. Finally, vertebrate agrins have three laminin G domains (lam G), while AGR-1 
has only two and no EGF-like domains separating them. The overall similarities of the different agrin 
segments to the corresponding regions of chicken agrin are indicated in Fig. 3. 
 
When the LamG domains from the C. elegans protein were used as a query against Swissprot, Trembl and 
Refseq databases the best hits besides the C. briggsae predicted agrin homologue (Q61GM7_CAEBR) 
included vertebrate agrins as well as laminins themselves and perlecans, shown in the alignments of Fig. 4A 
and 4B. In addition, a reciprocal analysis was done to see if some vertebrate agrin lamG domains produce 
best similarity hits with the nematode one. It turned out that the LamG domains of C. elegans agrin are quite 
distinct from those in vertebrates, and that the most similar lamG domains in vertebrates do not produce 
clear reciprocal best hits. This is not surprising since the LamG domains of the different proteins revealed 
equal similiarites to C. elegans agrin LamG domains (Fig. 4A,B). However, blast searches with each AGR-1 
LamG separately resulted in a better match between the first C. elegans lamG and the second LamG from 
several vertebrate homologues, as well as between the second C. elegans LamG and the third LamG domain 
of vertebrate agrins (Fig. 4A and B). This implies that the two LamG domains of C. elegans agrin rather 
correspond to the last two LamG domains of vertebrate agrin. This is further supported by the alignment of 
the region preceding the second LamG domain of AGR-1, which aligned best to the chicken B0 agrin 
isoform, i.e. it does not contain any inserts at the conserved B/z site (Fig. 4C). Based on the overall domain 
architecture of C. elegans agrin we conclude that AGR-1 is the nematode agrin orthologue and not an 
orthologue of any other lamG domain-containing protein. 
 
 34 
Results – Submitted manuscript 
Agr-1 is expressed in C. elegans buccal epithelium, dorsal and ventral IL1 head neurons, and distal tip 
cells of developing gonad, but not in body wall muscles 
 
To determine the expression pattern of the agr-1 gene, we made different agr-1::reporter fusion constructs, 
containing up to 5421 bp upstream of the first exon and up to 3275 bp of sequence downstream of the 
translational start codon including the large intron after exon 4 (Fig. 5A). Another construct containing the 
gfp gene flanked by agrin genomic sequences was co-injected with the cosmid F09G5. Upon recombination 
the gfp gene was integrated in the cosmid sequence and fluorescence could be observed in the transgenic 
lines (Fig. 5A). All five constructs gave the same expression pattern. Fluorescence started to be visible in 
cell clusters of young embryos at the 100-cell stage (Fig. 5B and C). Starting from the comma stage, 
expression became restricted to the head region of the embryo (Fig. 5D and E). The L1 and L2 larvae (Fig. 
5H and I, respectively) and young adults (Fig. 5F and G) expressed the marker in the nine buccal epithelial 
cells (dotted-line arrows), four head neurons (arrows), some unidentified cells in the head, and in the 
posterior-most cells of the gut (asterisk). The expression in the four neurons and buccal epithelium remained 
constant throughout the four larval stages and in the adult animal. Starting from the L2 stage, when gonad 
development and migration begins, fluorescence became also visible in the distal tip cells of the gonad (Fig. 
5I). 
 
To identify the four head-neurons expressing agr-1, we stained amphid neurons with DiI in the hdEx25 
transgenic lines, with or without 50mM CaAcetate. We did not find any co-staining between the red and 
yellow fluorescing dyes in these experiments, suggesting that the four neurons were neither amphids, nor 
IL2 neurons (Fig. 6A-F). We then analyzed agr-1::dsRED expression in the kdEx71; otIs107(ser-2::gfp) 
[146] and in the kdEx71; adIs1240(eat-4::gfp) [124] transgenic lines. No co-staining was observed in 
kdEx71; otIs107 (results not shown), suggesting that the neurons expressing agr-1 are not the OLQ neurons. 
In the kdEx71; adIs1240 animals the dorsal and the ventral, but not the lateral IL1 neurons co-stained for the 
red and green markers, allowing us to identify the agr-1 expressing neurons as the dorsal and ventral IL1 
neurons (Fig. 6G-I). 
 
In vertebrates agrin plays an important role in synaptogenesis at the neuromuscular junctions and in muscle 
stability (reviewed in [13]), therefore we carefully looked whether agr-1 is expressed in muscles and 
neurons in the nematode. We did not observe any marker expression in muscles and motoneurons in the 
worm, implying that the gene is not expressed in these tissues or is expressed at undetectable levels. 
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Agr-1 does not interact genetically with genes important for synaptogenesis and muscle stability in the 
worm. 
 
To further investigate the possible involvement of agr-1 in synaptogenesis and muscle stability, we tested 
possible genetic interactions between agr-1 and factors involved in these processes in the worm. The agr-
1(eg1770) single mutant did not show any obvious phenotype and its movements and co-ordination seemed 
normal. We tested the sensitivity to aldicarb and levamisole of the agr-1(eg1770) single mutant and in the  
lev-1(e211) [111], and dys-1(cx18); dyb-1(cx36) [147,148] backgrounds. The eg1770 mutation did not 
influence cholinergic activity in these backgrounds suggesting that the agr-1 gene does not play a role in the 
biogenesis and activity of cholinergic synapses in the worm. 
 
In order to investigate possible genetic interactions of agrin and the components of the DGC complex in C. 
elegans, we generated double and triple mutants with agr-1(eg1770) and the components of the dystrophin-
glycoprotein-complex. The crosses were done with mutants for dystrophin dys-1(cx18), dystrobrevin dyb-
1(cx36), dys-1(cx18); dyb-1(cx36); transcription factor MyoD1 hlh-1(cc561) that was shown to enhance the 
phenotypes of hypomorphic muscle mutants [149]; components of the extracellular matrix perlecan unc-
52(gk3), unc-52(e444), collagen cle-1(cg120), and nidogen nid-1(cg119) [150]; and with the cell adhesion 
factor dig-1(n1321). Locomotion in normal conditions or under stress in thrashing assays, response to touch, 
viability, and muscle integrity by staining the muscle fibers either with rhodamine-phalloidin [151] or in 
stEx30(myo-3::gfp) [152] were investigated in the single, double and triple mutant strains. The agr-
1(eg1770) mutation did not aggravate any of the phenotypes of the different mutant backgrounds, 
suggesting that agr-1 function is dispensable in the muscles of the worm. 
 
 
Specific monoclonal and polyclonal antibodies detect agrin in the basal lamina of the pharynx 
 
To confirm the agrin expression pattern at the protein level and to obtain more information on its possible 
function in the nematode, we raised specific antibodies against the lamG domains (Fig. 7A). The first lamG 
domain was expressed in E. coli, purified and used as antigen to raise monoclonal antibodies. A fragment 
containing both lamG domains was fused to a short sequence of chicken tenascin-C (Tn-C), expressed in 
HEK293EBNA cells, purified from the conditioned media and used to raise polyclonal antibodies. The 
specificity of both polyclonal and monoclonal antibodies was tested by western blotting and 
immunostaining of COS cells transiently transfected with the TN-C-agrin fusion construct (Fig. 7). In the 
conditioned medium, a band of around 80 kDa, which corresponds to the size of the recombinant protein, 
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was detected by all antibodies. The polyclonal serum recognized additional smaller fragments which 
probably correspond to protein degradation products. Transfected and non-transfected cells were stained 
with the anti-agrin monoclonal antibody pool (Fig. 7C-F) as well as the monoclonal antibody against the 
TN-C epitope tag (Fig. 7G-J). In the permeabilised cells (Fig. 7D and H), the overexpressed fragment could 
be detected mainly in the Golgi apparatus while in non-permeabilised  cells (Fig. 7C and G) the agrin 
protein could be detected in patches bound to the plasma membrane. This represented a first indication that 
the COS cells may express a surface receptor that binds agrin. Non-transfected COS cells did not give any 
immunfluorescence signal (Fig. 7 E-J). 
 
In order to detect the endogenous worm agrin protein, we analyzed worm extracts by western blotting with 
purified anti-agrin polyclonal antibodies. We compared extracts from wild type worms with the three agrin 
mutants available, agr-1(eg1770), agr-1(eg153) and agr-1(tm2051) described in Experimental procedures. 
Extracts were prepared from about 50µl of synchronized young larval stages (L1 and L2). The fractions 
soluble in RIPA buffer, including 6M urea, are presented in Fig. 8A. Two bands, one of about 160 kDa and 
the other of about 75 kDa, were detected by anti-agrin antibody in the lysate of wild type worms, but not in 
any of the three agrin mutant strains. The 160 kDa band corresponds to the calculated weight of the full 
length agrin protein, while the smaller band could represent a degradation product. Two additional bands 
(asterisks) which were present in all analyzed strains, seem to be due to a non-specific reactivity.  
 
To localize the agrin protein in worms, they were co-stained with the monoclonal antibody pool against C. 
elegans agrin and anti-rim, a pre-synaptic marker prominent in the nerve ring [153]. The major site of agrin 
expression was around the pharynx and the staining was particularly enriched in the anterior part (Fig. 8B). 
The posterior bulb staining was weaker probably due to poor antibody penetration. Polyclonal antiserum 
staining resulted in the same staining pattern in wild type worms of different developmental stages (Fig. 8C 
and D). Young larvae (L1) generally showed stronger agrin staining compared to young adults (C compared 
to D, respectively). Pharyngeal staining was absent in all three agrin mutant strains, which is an additional 
confirmation for their lack of agrin expression (Fig. 8F-H). In addition to the pharynx staining in the wild 
type worms, the polyclonal antiserum stained the gut lumen (arrowhead) both in the wild type worms as 
well as in the agrin mutants, but not when preimmune serum was used instead. The staining of the lumen of 
the gut represents an unrelated cross-reactivity of our antiserum, possibly related to the background bands 
detected on the western blots.  
 
The strong pharyngeal localization led us to suspect that agrin has a pharynx-related function, namely in 
feeding behavior or structural stability. Therefore, we investigated the pharyngeal pumping rate of normal 
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versus mutant animals, but could not detect any differences. Despite the absence of agrin in the pharynx of 
the mutants, pharyngeal morphology was normal in young as well as in the older animals (data not shown). 
To challenge the pharynx function, we fed agrin mutants with different strains of bacteria of various sizes 
[120]. However, even ingestion of the largest bacteria, strain Bacillus Megaterium, did not result in a 
different growth rate as compared to the wild type animals.  
 
Recombinant fragment of C. elegans agrin binds to purified chicken α-dystroglycan 
 
Based on the well described binding of agrin to α-dystrolgycan in vertebrates [47,80], we addressed this 
possible interaction in the case of C. elegans agrin. The interaction between agrin recombinant fragment 
containing two lamG domains and dystroglycan was tested biochemically by a protein overlay assay. 
Purified chicken α-dystroglycan was run on an SDS PAGE and blotted to a nitrocellulose membrane. 
Separate strips of this membrane were incubated either with conditioned medium containing the 
recombinant C. elegans agrin fragment, or with purified recombinant chicken agrin fragments representing 
the muscle agrin isoform lacking inserts in the A/y and B/z sites or with the neuronal isoform with 4 and 8 
amino acid inserts at the respective sites. Following several wash steps, agrin bound to α-DG was detected 
with anti-Tn60 antibodies that recognize the short TnC part fused to agrin (Fig. 9). The chicken muscle 
agrin fragment, which served as positive control bound efficiently to dystroglycan, appearing as a dark 
smear caused by the migration behaviour of the highly glycosylated distroglycan (Fig. 9, lane 1), while the 
neuronal isoform gave a very weak signal at the dystroglycan protein core size of approximately 200 kD 
(lane 2). The C. elegans agrin fragment also bound to DG and was detectable as a smear on the membrane 
strip simiar to the chicken muscle agrin (Fig. 9, lane 3). Conditioned medium from non-transfected cells was 
used as negative control and did not result in a signal (lane 4). This result indicates that the C. elegans agrin 
retains the binding to α-dystroglycan. 
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C. elegans agrin induces endogenous dystroglycan clustering in COS cells 
 
The interaction between C. elegans agrin and DG was further investigated in cell cultures of COS cells, 
transfected with the recombinant fragment of C. elegans agrin (fragment 2 in Fig. 3). Transfected cells 
secreted the agrin fragment into the medium where it bound to the cell surface in a patchy pattern (Fig. 10 A 
and D). Remarkably, the dystroglycan staining followed the same pattern (Fig. 10 B and E) and overlapped 
with the agrin staining in patches (Fig. C and F), while the dystroglycan staining of untransfected cells 
showed a diffuse membrane staining (Fig. 10 H and K). The anti-β-DG antibody recognizes the intracellular 
part of the protein, therefore only permeabilized cells showed strong staining (Fig. 10E). Immunostaining 
experiments with the pool of the monoclonal anti-agrin antibodies resulted in the same pattern as with 
polyclonal antibodies (data not shown), but co-staining with anti-β-DG was not possible due to the same 
host species in which the antibodies were raised. Our results suggest that the recombinant agrin fragment 
containing the two lamG domains bound to the cell membrane, probably through direct interaction with 
dystroglycan. Interestingly, the endogenous dystroglycan had a diffuse pattern in cells without agrin 
overexpression, but it appeared clustered by agrin secreted from the transfected cells, suggesting that agrin 
bound to the cells and induced clustering of DG.   
 
 
 39
Results – Submitted manuscript 
Discussion 
 
We have identified and characterized the first invertebrate agrin. In terms of domain structure, a high degree 
of similarity was found between C. elegans and vertebrate agrins, although some domains were missing. In 
the worm, only one N-terminal variant was detectable containing a secretion signal, but no NtA domain [10]. 
Several other domains were missing, namely the Ser/Thr-rich region, the SEA module, and one of the three 
lamG domains at the C-terminal end of the molecule. We analyzed the two lamG domains present in the 
worm and compared them to the vertebrate lamG domains to determine whether they corresponded to a 
particular domain pair of vertebrate agrin. Blast searches revealed that the AGR-1 LamG domains aligned 
better to the last two LamG domains of vertebrate agrin. However, we could not detect any small inserts 
known to be important for the clustering function of the vertebrate neuronal agrins [23,24]. There still 
remains the possibility of an alternatively spliced agrin isoform present in the worm, much less abundant or 
expressed in a particular developmental stage, which was not possible to be amplified and detected in the 
presence of the major isoform. Nevertheless, when we searched the intron sequences between the last few 
exons encoding the LamG domains in all three frames, we could not detect any potential alternative exons 
coding for conserved amino acid resembling inserts present in the A/y and B/z sites of vertebrates. 
Therefore, we concluded that in C. elegans there is only one major agrin isoform expressed. 
 
With the goal to detect the endogenous agrin by western blot, we raised specific polyclonal antibodies 
against the fragment comprising two lamG domains. Purified antibodies detected protein bands of about 160 
kDa and 75 kDa, present only in the lysates of the wild type worms and not in any of the agrin mutants. The 
bigger band corresponded to the protein core size and the smaller possibly to a degradation product or a 
shorter isoform. In the null mutants agr-1(eg1770) and agr-1(eg153) we expected a complete lack of the 
protein, but agr-1(tm2051) carried an in-frame deletion and was expected to express a shorter protein. 
However, in agr-1(tm2051) mutant the deleted exons 26 and 27 encode the majority of the region against 
which the polyclonal antibodies were raised. Therefore, such a truncated protein may not be recognized and 
no band detected although the protein may be expressed. Another possibility is that the protein with the 
deletion does not fold properly and gets degraded. In any case, it is clear that the agrin mutants do not 
express the normal agrin protein as the wild type worms do. 
 
The most surprising result of our study was the fact that we could not detect any agrin expression neither in 
body wall muscles nor in motoneurons innervating them. The lack of agrin expression at the NMJs 
suggested that agrin may not have a conserved function in AChR clustering in the worm. Nevertheless, we 
investigated the possible phenotypes in C. elegans agr-1 mutants related to muscle and/or NMJ function. In 
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the case of defective muscle or NMJ formation, worms should have an uncoordinated (unc) movement, a 
defective thrashing pattern, and/or egg laying deficiency. However, we did not observe any significant 
impairment neither in agr-1 single mutants, nor in combination with other related mutations. 
Pharmacological assays with levamisole, a potent nematode-specific cholinergic agonist [110] and aldicarb, 
an ACh esterase inhibitor [154], did not reveal any resistance in agr-1 mutants. Therefore, in C. elegans we 
could not find any evidence for a role of agrin in muscle or synaptic functions.  
 
Therefore, we concentrated more on the sites of agrin expression visualized by reporter genes and antibody 
staining. Prominent expression was found in four head neurons and some pharyngeal cells. This relatively 
restricted expression pattern was quite unexpected but was confirmed by several reporter constructs with 
varying portions of the gene as well as by antibody staining. 
We identified the four agrin-expressing neurons by crossing agr-1::dsRED worms with transgenic lines 
expressing GFP in specific neuron subtypes [124]. This approach suggested that the agrin-expressing 
neurons corresponded to IL1, inner labial sensila polymodal neurons. These are mechanosensory, 
motoneurons and interneurons at the same time [98]. There are six IL1 neurons in total (three pairs) in the 
head of the worm [93], but agrin was found to be expressed only in the dorsal and ventral pairs. Such a sub-
specialization might be significant to distinguish very fine sensory inputs from the environment. It is known 
that IL1 neurons together with OLQ neurons are responsible for the sensing of a light nose touch and the 
regulation of spontaneous foraging movements [98]. Therefore, we tried to test agrin mutants for light nose-
touch-avoidance by an eyelash test [97], but agrin mutants seemed to be as sensitive to touch as the wild 
type worms. We cannot exclude, however, that our technique was too crude to find a difference. 
 
The pharyngeal cells expressing agrin belong to the buccal epithelium which surrounds the anterior-most 
part of the pharyngeal lumen ([118], Wormatlas, http://www.wormatlas.org/). In early larvae agrin is in 
addition expressed in other, unidentified cells of the pharynx, most likely marginal cells. The epithelial 
tissue forms a rigid narrow cylinder restricting the food entry into the pharynx [118]. Agrin expressed in this 
tissue might have a function in the structural support of the pharynx. The immunostaining with anti-agrin 
specific monoclonal and polyclonal antibodies detected the protein around the pharynx, resembling perlecan 
immunostaining in the pharynx basal lamina [131]. Thus, agrin is probably secreted from the pharyngeal 
cells and integrated into the basal lamina. This pharyngeal staining was missing in all three agrin mutant 
strains. Therefore, we analyzed pharynx function in the mutants. The pharynx is a muscle pump important 
for food intake, exposed to strong contractions with the frequency of about 4 pumps per second in the 
presence of bacterial food [155]. Therefore, strong mechanical support of the pharynx is necessary to endure 
the shear forces to which it is exposed. Pharynx function was tested by measuring the pumping rate, which 
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did not differ between the agrin mutants and the wild type worms. To challenge pharynx function more 
drastically, we tested whether bacterial size had any influence on the feeding and ingestion capability of the 
worms. For that purpose we grew the worms on Bacillus megatherium, a large bacterial strain and compared 
it to the regular E. coli OP50 strain used in regular laboratory maintenance [120]. Pumping defective mutant 
strains eat-4(ky5) and eat-5(ad464), which grow much more slowly on large bacteria, were used as positive 
controls. On both food sources our agrin mutant agr-1 (eg1770) grew equally fast as wild type worms. Also 
pharynx morphology did not seem defective in the agr-1 (eg1770), suggesting that if agrin has a function in 
pharynx-related functions, it is subtle or redundant. 
Some expression of agrin was present in the distal tip cells of developing gonads in young larvae. The distal 
tip cell is critical for germ line proliferation and guides gonad migration by sensing environmental cues 
[132,156]. We have investigated a possible effect of agrin deficiency in gonad migration or brood size, but 
the mutants could not be distinguished from the wild type worms.  
 
Interaction between agrin and α-dystroglycan in vertebrates is important in different tissues and processes 
(reviewed in [13,157]). At the NMJ, DG stabilizes mature synapses by connecting the basal lamina to 
cortical F-actin. In the muscle sarcolemma DG is a central component of a large dystrophin-glycoprotein 
complex (DGC) where it serves again as a linker between the ECM and intracellular cytoskeletal proteins 
(reviewed in [60,141]). At the NMJ and the muscle membrane agrin interacts with α-DG with its C-terminal 
lamG domains and with its N-terminal part to laminin therefore providing additional support. Interaction 
between agrin and DG is found to be conserved also in the immune system, where this binding mediates 
lymphocyte activation via a lipid raft-dependent mechanism [84]. Based on the established knowledge on 
the vertebrate agrin and DG, we decided to investigate whether this interaction is conserved in C. elegans. 
We could demonstrate direct binding of a recombinant fragment of C. elegans agrin to purified vertebrate α-
DG by a membrane overlay assay. In COS cells, transfected with the same recombinant fragment, 
endogenous DG was clustered and colocalized with the agrin bound to the cell membrane.  
 
Taken together, our experiments suggest that the interaction between agrin and dystroglycan may be 
conserved in C. elegans but this interaction does not play a role at the NMJ or in muscle in general. This is 
supported by the recent observation that also C. elegans dystroglycan, dgn-1, is not expressed in muscle, but 
rather in epithelia and neurons, it localizes to basement membrane surfaces and is not involved in muscle 
function, either [158]. Therefore, the structural organization at the molecular level of the NMJ, as well as 
the DGC complex, is clearly distinct in C. elegans as compared to vertebrates. Our studies demonstrate that 
the existence of protein orthologs in evolutionarily distant organisms [117] does not necessarily imply 
identical functions, at least not in every aspect. In C. elegans it appears that the muscle basal lamina 
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depends rather on the function of the perlecan orthologue unc-52 [104,130,131,150] and on the integrin 
chain orthologues pat-2 and pat-3 [126,136,159,160] and not on dystroglycan and its ligands [158]. On the 
other hand dystroglycan and agrin appear to function in epithelia and certain neurons but not in muscle. 
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Experimental procedures 
 
C. elegans culture conditions and preparation for RNA and protein extraction 
The worm strains were grown at 20°C on NGM agar plates seeded with E. coli OP50 [86]. For growth in 
large amount and further protein extraction, worms were grown at 20°C on 10 cm culture dishes with NGM 
medium and the addition of egg yolk [161]. In order to prepare synchronized cultures of young larvae, 
gravid worms were washed with M9 buffer and sucrose flotation [162], then bleached [163] followed by 
extensive washing in M9. The larvae hatched and, when they reached the L2 larval stage, were rinsed off 
the plates with M9 buffer, washed in M9, deionized water, and quick-frozen in liquid nitrogen. 
 
Sequence identification and cDNA cloning 
Total RNA was isolated from a mixed-stage worm population (Trizol reagent, Gibco) and reverse-
transcribed into cDNA using oligo dT primers and MMLV reverse transcriptase from AdvantageTM RT-for-
PCR Kit (Clontech) according to the supplier’s protocol. Agrin cDNA was amplified by using sets of 
primers designed according to the predicted gene sequences in the Wormbase (ACeDB: F41G3.15 and 
F41G3.12, as of January 1, 2003; presently, only one common ORF exists in the database under the name 
F41G3.12) in order to obtain overlapping PCR products using the following primers: agr3 and agr6; agr1 
and agr2; agr9 and agr12; agr25 and oligo dT primers listed in Table 1. In parallel, a commercial C. elegans 
cDNA libray (OriGene Technologies) and the EST clone Yk1264e03 (vector pME18S-FL13, kindly 
provided by Dr. Yuji Kohara) were used as templates. The 5’UTR was determined with 5’ RACE approach 
(Roche) following the supplier’s protocol. Agrin cDNA sequence was assembled from overlapping 
fragments resulting in an open reading frame (ORF) of 4422 bp.  
 
Protein architecture analysis and alignments with vertebrate orthologues  
Protein architecture was analysed with SMART (EMBL, [144]), and with Blast at ExPASy [164]. Several 
overlapping domains were predicted, but in this report only a representative structure is presented based on 
the similarity to the vertebrate orthologues. Laminin G domains of C. elegans agrin were used as a query in 
myHits [165] against Swissprot, Trembl and Refseq. After the analysis of a more extensive alignment, the 
most informative Swissprot hits were selected. Visualization was done in Jalview, using Zappo colors 
without conservation threshold, to analyze subgroups [166]. Alignments were submitted to the Boxshade 
server at Pasteur (http://bioweb.pasteur.fr/seqanal/interfaces/boxshade.html) for producing the greyscale 
shading. Pairwise comparison of sequences (% identity / % similarity) was performed using Smith 
Waterman alignments (as implemented in water, a tool in the EMBOSS package; [167]. The homology 
searches between fragments of C. elegans agrin sequence and chicken agrin were done at myHits (SIB) 
 44 
Results – Submitted manuscript 
using iterative PSI-BLAST searches [165]. The C. elegans fragment composed of 2 lamG, yielded different 
Blast scores for alternatively spliced chicken agrin isoforms (Swissprot), which was due to the presence, or 
absence, of the spliced exons. The alignments of the conserved alternative splicing site were produced by 
Blast at ExPASy. 
 
Agr-1::reporter expression constructs for expression pattern analysis 
Agrin fragments were cloned following standard procedures [168]. The constructs used to create transgenic 
animals were the following: 
Pagr-1::dsRED (p251). A 1926 bp genomic DNA fragment immediately upstream of the agr-1 ATG start 
codon was amplified using the primers E149 and E150 (the sequences of the primers are listed in Table 1). 
The SalI site near the start codon was removed by introducing a point mutation in the sequence of primer 
E150 (bold and underlined in Table 1). The PCR fragment was then cloned into the SphI-SalI sites of the 
vector pVH14.05 that contains the dsRED gene (pVH).  
Pagr-1::yfp (pVH11.07). A 1527 bp genomic DNA upstream of the agr-1 ATG start codon was amplified 
with the primers XY1 and XY2 and cloned into the PstI-XbaI sites of pVH20.01 (promoterless yfp vector) 
Pagr-1::gfp (5.5Kb) (p130). A 5431 bp genomic DNA fragment including 5421 bp of promoter sequence 
and the first 12bp of the agr-1 ORF was amplified with the primers E32 and E33. The fragment was then 
ligated into the SphI-XbaI sites of the pPD95.75 vector (Fire Lab vector kit). The NotI and ClaI sites 
introduced with the primer E33 are needed for further cloning (see below). 
Pagr-1::gfp (8.6Kb) (p143). A 3198 bp genomic DNA fragment from the 5’ region of the agr-1 gene was 
amplified with the primers E34 and E35 and cloned into the ClaI-NotI sites of the pagr-1::gfp (5.5Kb) 
plasmid. The pagr-1::gfp (8.6Kb) plasmid contains 5421 bp of promoter region and the agr-1 genomic 
region covering the first seven exons and introns (the primer E35 primes on the 5’end of exon 8). 
Furthermore, primer E34 was chosen downstream of the putative signal sequence on exon1; the signal 
sequence is therefore not present in the construct. 
Pagr-1::gfp::agr-1 (p233). The gfp ORF was amplified from pPD95.75 with the primers E36 and E37 and 
ligated into the ClaI site of pagr-1::gfp (8.6Kb). A TAG stop codon terminates translation at the end of the 
gfp ORF. Orientation and sequence of the insert were checked. The gfp gene flanked by agr-1 sequences 
was then excised from the plasmid with AflII and SgrAI, gel purified, and co-injected (20ng/µl) with the 
cosmid F09G5 (100ng/µl). 
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Transgenic strains 
The agr-1::reporter constructs were injected at a final concentration of 50 ng/µl in wild type N2 animals or 
in dpy-20(e1282). As markers, a plasmid containing a dpy-20+ genomic fragment (primers E42 and E43, 
plasmid p133) or pRF4 (rol-6(su1006)) were co-injected at a final concentration of 10ng/µl [169]. 
Integration of the extrachromosomal arrays was induced by UV294 irradiation and the integrated strains 
were then backcrossed 10 times in N2 to remove unwanted mutations.  
 
Agrin mutant strains 
Three mutations in the agrin gene were isolated. The agr-1(eg1770) and agr-1(eg153) mutants were created 
by Mos-driven mutagenesis and were kindly provided by Dr. Jean-Louis Bessereau [170]. In the agr-
1(eg1770) mutant strain the Mos1 transposon was inserted into the seventh exon (after the base pair at the 
position 4948, according to the numbering in the cosmid T13C2) and brings the transcript out of frame, 
therefore causing a putative null mutation.  The agr-1(eg153) agrin mutation was created by transposon 
mobilization which led to an imprecise excision and left an insertion of five base pairs (“TGATA” at the 
position after 4948 of cosmid T13C2) from the agrin ORF and gave rise to another putative out-of-frame 
null mutation. The third mutant, agr-1(tm2051), was kindly provided to us by the National BioResource 
Project, the Japanese C. elegans knock-out consortium. The mutant carries an in-frame deletion of 423 bp 
including exons 26 and 27 (nucleotides 22165-22587 of cosmid F41G3), which encode the last laminin G 
domain and therefore disrupt a potentially functionally important site of the gene [27].  
 
Analysis of agrin mutants 
Agrin mutants were analyzed for potential defects at the neuromuscular junction, by pharmacological 
treatments with aldicarb and levamisole, following previously described procedures [110,154].  
Based on the expression of agrin in the worms’ pharynxes, different related phenotypes were investigated as 
described previously: pharyngeal pumping rate, pharyngeal morphology [171], and worms’ feeding on large 
bacteria [120]. 
 
Staining of amphid neurons 
Amphid neurons were stained with 1,1'-dioctadecyl-3,3,3',3'- tetramethylindocarbocyanine perchlorate (DiI, 
Invitrogen D-282) [172]. Young adult hermaphrodites were incubated in M9, 5µg/ml DiI (with or without 
50mM CaAcetate) for two hours at room temperature, washed three times in M9 and transferred to a NGM 
plate with E. coli OP50. After two hours the worms were mounted on agarose pads with 30mM Na Azide 
[154] and analyzed with a Zeiss LSM510 confocal microscope. 
 
 46 
Results – Submitted manuscript 
Cloning, expression and purification of agrin fragments 
 
Cloning of the first lamG domain, bacterial expression, and purification 
Agrin cDNA coding for the first laminin G domain was amplified with primers containing restriction sites: 
lam3 (SphI) and lam6 (HindIII) listed in Table 1. The 513 bp PCR product was digested by SphI and HindIII 
restriction enzymes and cloned into the pQE30 vector (Qiagen) containing a 6xHistidine (6xHis) tag just 
upstream of the multiple cloning site. Expression and purification were done following the QIAexpressionist 
protocol (Qiagen) under denaturing conditions. The purified agrin fragment of 25kD was analyzed by SDS-
polyacrylamide gel electrophoresis (SDS PAGE) and stained with Coomassie blue (GelCode, Pierce). 
Fractions of the elution peak were pooled and dialysed against PBS- for further experiments. 
 
Cloning of both lamG domains and expression in eukaryotic cells 
The agrin fragment encoding both laminin G domains and the C terminus of the protein, was amplified by 
specific primers, named overlap5’ and lam8euk4 (Table 1). The amplified agrin fragment of 1203 bp was 
fused to an N-terminal fragment of chicken tenascin-C  containing a signal sequence and the epitope for the 
monoclonal anti-tenascin-C (TNC) antibody anti-Tn60 [173]. The TNC fragment was amplified from pCTN 
230 [174] with T3 as the upstream primer and an antisense primer of which the 3’ half was homologous to 
the template sequence and the 5’ part reverse complementary to the beginning of the agrin fragment (primer 
agr/TN antisense, Table 1). The two fragments were fused by PCR using the T3 and lam8euk4 primers. The 
resulting fusion product of 2100 bp was digested with restriction enzymes Cla I and Not I and cloned into 
pKSII. Insertion was verified by sequencing and the fragment cloned into the Kpn I and Not I restriction 
sites of the expression vector pCEP for expression in HEK293EBNA cells. The cells were transfected with 
the FugeneTM6 reagent (Roche) following the supplier’s protocol. Since the recombinant agrin fragment 
contained the signal peptide of vertebrate TNC, the protein product was secreted into the conditioned 
medium which was then tested by western blotting with anti-Tn60.  
For large scale protein expression the cells were grown in 15cm tissue culture dishes in DMEM/10%FCS 
until they reached 75% confluency. Then the cells were washed with DMEM without FCS and 24 to 48 
hours after the medium change two liters of serum-free conditioned media were collected. The agrin in the 
conditioned medium was precipitated with 50% ammonium sulphate at 4˚C. The pellet was resuspended in 
PBS-/0.1% Tween and dialysed overnight against the same buffer. Agrin was purified over a anti-Tn60 
affinity column as described previously for recombinant TNCs [174]. Elution fractions were analysed by 
SDS-PAGE and western blotting. The fractions containing peak amounts of agrin fragment were pooled and 
dialysed against PBS-. Alternatively, precipitated conditioned media were dialysed against PBS- overnight 
and DMEM for one hour to be used for in vitro binding assays with dystroglycan (see below). 
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Monoclonal and polyclonal antibodies against C. elegans agrin 
The recombinant agrin fragment expressed in E. coli was used as antigen for the immunization of mice to 
raise monoclonal antibodies. Conditioned media from hybridoma clones were tested for antibody production 
and specificity. The activity was determined by ELISA tests and western blots using recombinant agrin 
protein encompassing both lamG domains expressed in eukaryotic cells. Four hybridoma clones were 
positive, their cultures were expanded, and the antibodies from conditioned media were concentrated over 
protein G columns. In further experiments a pool of the purified monoclonal antibodies was used. 
Polyclonal antibodies were raised in two rabbits (AG1 and AG2) against the recombinant agrin fragment 
containing both lamG domains fused to a short epitope of TNC. Antisera were tested by western blot and 
immunofluorescence for the specificity to the agrin fragment and preimmune sera, taken from the rabbits 
just before the immunization, served as negative control. To purify monospecific antibodies from these 
antisera the recombinant agrin fragment, which was used as antigen was bound to CNBr-activated 
SepharoseTM 4B resin (Amersham Pharmacia) and packed into a column. Polyclonal antiserum from rabbit 
AG1 was loaded on the column, the column was washed, bound antibodies eluted, and their activity tested 
by western blots of the recombinant protein. These highly purified antibodies were used for the detection of 
endogenous agrin in C. elegans. 
 
Western blots 
The purified agrin fragment of two lamG domains was run on 7.5% SDS PAGE  [175] and transferred onto 
Immobilon membrane (Millipore). The membrane was blocked for one hour in 5% non-fat dry milk (Fluka) 
in TBS/Tween-20 (0.05%) (Fluka) with gentle agitation at room temperature. Incubation with primary 
antibodies was carried out overnight at 4˚C slowly rocking. The anti-agrin purified monoclonal antibody 
pool was diluted 1:1000 and whole polyclonal antisera 1:8000 in blocking solution (5% non-fat dry milk in 
TBS/Tween-20). The following day membranes were washed over one hour with several changes of 
TBS/Tween-20, followed by incubation with goat anti-mouse or goat anti-rabbit horseradish peroxidase 
(HRP) - conjugated secondary antibodies (Cappel, MP Biomedicals), diluted 1:2000 in 5% milk, during one 
hour at room temperature. After extensive washing in TBS/Tween over more than one hour, protein on the 
membrane was visualized by ECL reagent (Amersham Biosciences) and exposed on Kodak Biomax MR 
film. 
To detect endogenous worm agrin by western blotting young larval stages were homogenized in ice-cold 
RIPA buffer (NaCl 150mM,  TrisHCl pH8 50mM,  NP-40 1%, deoxycholic acid 0.5%, SDS 0.1%, NaF 
50mM) containing a cocktail of protease inhibitiors (Complete Mini EDTA-free, Roche). The suspension 
was centrifuged for 30 minutes at 14000 rpm in a tabletop centrifuge at 4˚C. The supernatant was kept and 
the pellet resuspended in RIPA buffer including 6M urea and centrifuged for additional 30 min at RT. The 
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supernatant was separated and the pellet resuspended in reducing sample buffer (SB+) with 6M urea. All 
fractions were heated for 5 minutes at 95˚C and run on a 6% SDS PAGE, followed by western blotting, as 
described above. Purified polyclonal antibodies (AG1) were diluted 1:500 in the blocking solution and anti-
rabbit secondary antibody 1:10000. Immunoreactive proteins were visualized by the HRP substrate Super 
Signal (Pierce) exposed to double-coated ML film (Kodak) for 1 minute. 
 
Immunofluorescence 
COS cells were grown in 35mm tissue culture dishes and transfected with pCEP-Agrin using Fugene 6 
reagent (Roche). 24 hours after transfection the cells were rinsed with PBS+ and fixed with 4%PFA in PBS- 
for 15 minutes at room temperature. Some dishes were permeabilized with 0,1% TritonX-100 (Fluka) in 
PBS- during 5 minutes at room temperature, while some were left non-permebilized for control. After 
rinsing with PBS-, the cells were blocked with 3% goat serum in PBS- during 15 minutes at room 
temperature. Primary antibodies were diluted 1:100 in blocking solution and incubated 2 hours at room 
temperature. After washing in PBS-, the secondary antibody was diluted 1:1000 in blocking solution and 
incubated on cells for one hour at room temperature in the dark. Goat anti-mouse and goat anti-rabbit FITC 
antibodies (Alexa 488, Molecular Probes) were used on separate samples of cells. Together with the 
secondary antibodies, Hoechst dye (Fluka) was added at dilution 1:1000 for visualization of cell nuclei. 
Cells were washed with PBS-, rinsed with deionized water to remove traces of salt, and mounted with 
ProLong Gold antifade reagent (Invitrogen). The pictures were obtained on a Zeiss Z1 automized upright 
fluorescence micoscope for multi-dimensional acquisition. The same conditions were used for all the 
samples, 100x magnification, exposure of 500 ms for FITC and 80 ms for Hoechst. 
To simultaneously stain for agrin and endogenous β-dystroglycan in COS cells, cells were treated as 
described above. The anti- agrin polyclonal antiserum was used at 1:100 dilution and the monoclonal anti- 
β-dystroglycan antibody 43DAG1/8D5 (Novocastra, kindly provided to us by Prof. Markus Rüegg) at 1:100 
dilution in blocking solution. The β-dystroglycan antibody was visualized by a goat anti-rabbit secondary 
antibody coupled with a red dye (Alexa Fluor® 594, Molecular Probes) and anti-agrin by green-labelled goat 
anti-mouse (Alexa Fluor® 488, Molecular Probes). 
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Immunofluorescence staining of endogenous worm agrin 
Worms were immunostained following a modified Finney & Ruvkun protocol [176]. Mixed stages of 
worms, grown on NGM plates, were extensively washed in M9 buffer. The last wash was done with 
deionised water and the worms were quick-frozen on dry ice/ethanol in Ruvkun fixation buffer mix diluted 
from a 2x stock (160mM KCl, 40mM NaCl, 20 mM Na2EGTA, 10mM spermidine-HCl, 30mM Pipes, pH 
7.4, and 50% methanol) with the addition of 1.5% formaldehyde. Following permeabilization by freeze-
thaw in three cycles, worms were fixed for 1 hour on ice. The cuticle reduction and final permeabilisation 
was done by TTB and 1% β-mercaptoethanol overnight, slowly rotating at 37˚C. Permeabilization was 
completed the following day by 10mM dithiothreitol (DTT) in 1x BO3 buffer (diluted from 20x stock: 1M 
H3BO3, 0.5M NaOH), including 0.01% Triton and 0.3% H2O2 in the same buffer for additional 15 minutes. 
The worms were blocked in AbB buffer (1x PBS, 0.1% BSA, 0.5% TritonX-100, 0.05% Na-azide, and 
1mM EDTA) and immunostained with the antibody solution in the AbA buffer (1% BSA) overnight at 4˚C 
with gentle rocking. The mouse monoclonal anti-agrin antibody pool used at 1:200 dilution, the rabbit 
polyclonal anti-agrin antibody at 1:100, and a rabbit polyclonal anti-rim antibody 1:6000 [153]. The anti-rim 
was kindly provided by Prof. Michael Nonet. Worms were washed with AbB during several hours and 
incubated with the secondary antibody at 1:1000 dilution in AbA buffer at room temperature gently rocking 
in the dark during two hours. For agrin monoclonal antibodies anti-mouse secondary antibody conjugated 
with a green dye (Alexa Fluor® 488, Molecular Probes), for polyclonal anti-agrin secondary anti-rabbit 
labeled green (Alexa Fluor® 488, Molecular Probes) and for rim polyclonal antibody red-labeled anti-rabbit 
(Alexa Fluor® 546, Molecular Probes) was used. Following extensive washing in AbB during two hours, the 
worms were mounted on glass slides with Mowiol (Dabco) mounting medium. Images of agrin / rim co-
staining were obtained by a confocal LSM510 META Axioplan2 microscope and for single agrin stainings 
by the polyclonal antibody a Zeiss Axioscope Bio microscope was used.  
 
In vitro assay for agrin - β-dystroglycan binding 
Purified chicken α-dystroglycan [33]; kind gift from Prof. Markus Rüegg) was run on 7.5% SDS PAGE and 
transferred to a nitrocellulose membrane. The membrane was blocked for two hours in blocking buffer (PBS, 
0.05% Tween-20, 1mM CaCl2, 1mM MgCl2, 5% milk). The membrane was cut in strips which were 
incubated with different samples of agrin. Chicken recombinant agrin proteins were kindly provided by Prof. 
M. Rüegg [27]. The chicken agrin fragments were 120 kDa in size, containing 25 kDa of N-terminal 
laminin-binding domain (NtA) fused to all three C-terminal lam G domains of 95 kDa, differing only in the 
alternative splicing essential for dystroglycan binding [24]. The fragment of a splice variant of chicken agrin 
enriched in muscles was used as positive control for DG binding, the chicken agrin neural isoform as 
negative control, and C. elegans recombinant fragment containing two lamG domains was tested. Final 
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concentration of both agrin control samples was 4µg/ml. The incubation was carried out overnight at 4˚C 
with gentle agitation. The following day, membrane strips were washed in blocking buffer (5% milk in 
TBS/Tween-20). Detection of bound agrin fragments was performed as described for western blotting with 
minor modifications. The polyclonal anti-chick agrin antibodies were prepared by Dr. Shuo Lin and kindly 
provided to us by Prof. Markus Rüegg. Incubation with the primary antibodies was done during 3 hours at 
room temperature. Polyclonal anti-chicken agrin antibody was diluted 1:2000 in 5% milk blocking solution. 
The C. elegans agrin fragment was detected by anti-Tn60 [173] diluted 1:1000 in 3% BSA blocking 
solution. Following washing in 5% milk blocking solution, membrane strips were incubated with HRP-
conjugated goat anti-mouse antibody diluted 1:2000, during one hour at room temperature. After extensive 
washing in TBS/Tween proteins were visualized by ECL reagent (Amersham Pharmacia) and the 
membranes exposed to Kodak BioMax MR film.  
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Fig. 1. C. elegans agrin DNA and protein sequence with predicted domain architecture. The C. elegans 
agrin coding sequence was assembled from overlapping cDNA fragments, amplified by RT-PCR. The 
positions of the primers are shown by black arrows, where the corresponding pairs are depicted with the 
same line pattern (full line, dotted line, “dash-dot-dash” line). The three nucleotides missing in the genomic 
sequence of the database entry are framed with red rectangles. Based on the nucleotide numbering in cosmid 
F41G3, their positions are: C after 30028, A after 29776 and C after position 28351. The coding region of 
the gene is 4422 bp long with 5’ and 3’ untranslated regions of 212 and 160 bp, respectively (dark gray 
boxes). The predicted protein sequence is 1474 amino acids long and the domain architecture is shown in 
different colors. A putative signal sequence (purple box) is followed by seven follistatin domains (blue), two 
epidermal growth factor domains of the laminin-type (light gray), a follistatin domain (blue), an EGF-like 
domain (orange) and two laminin G domains (yellow).  
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Fig. 2. Genomic organization of the agrin gene and mutant alleles. The assembled transcript consists of 
29 exons which span over the chromosomal region of almost 14.5 kb on chromosome 2. Black arrows 
indicate the three locations where a nucleotide is missing in the database genomic sequence (exons 14, 15 
and 20; cf. Fig.1). Three mutations in the agrin gene were isolated. In the eg1770 mutant strain (black 
arrowhead) Mos1 transposon was inserted into the seventh exon what brings the transcript out of frame, 
therefore causing a putative null mutation. The eg153 strain (asterisk) was created by imprecise excision of 
the Mos1 transposon leaving 5 bp at the insertion site and resulting in a +2 frameshift mutation. Mutant 
tm2051 (dotted line) carries a deletion of 423 bp including exons 26 and 27 resulting in an in-frame loss of 
42 amino acids. 
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Fig. 3. Domain architecture of the C. elegans agrin protein in comparison to the vertebrate 
orthologues. C. elegans agrin starts with a signal sequence (SS; purple), followed by seven follistatin-like  
domains (F; blue), two epidermal growth factor (EGF) domains of the laminin-type (LE; gray), one 
follistatin-like domain (F; blue), an EGF-like domain (EG; orange), and two laminin G domains at the C 
terminus (LamG; yellow). The color scheme follows the same pattern as presented in the Fig. 1. Predicted 
N-glycosylation sites are shown with blue circles. Vertebrate agrins have two alternative N-termini: a 
secreted form, with a signal sequence (SS; dark purple) and a laminin-binding N-terminal agrin domain 
(NtA; light purple). These are followed by one follistatin domain more than C. elegans (F; blue), a sea 
urchin sperm protein, enterokinase and agrin domain (SEA; light blue), two serine/threonine rich regions 
(S/T; light orange), and three laminin G domains (LamG; yellow). O-linked heparan sulphate and 
chondroitin sulphate chains are schematically shown as branches and several N-linked glycoslation sites as 
blue circles. Alternative splicing at the last two LamG domains of vertebrate agrin (A/y and B/z) gives rise 
to several agrin isoforms with different functions, but no alternative splicing was found in C. elegans agrin. 
Three separate segments of C. elegans agrin marked by dashed lines were used in a Blast search. The 
resutling degree of identity/similarity to the corresponding parts of chicken agrin (Swissprot entry P31696-2) 
are indicated. Recombinant fragments 1 and 2 of C. elegans agrin indicated above the LamG domains were 
used as antigens for raising monoclonal and polyclonal antibodies, respectively. 
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Fig. 4. Alignment of the C.elegans lamG domains to the corresponding domains of other proteins.  
Results – Submitted manuscript 
A. The first LamG domain of the C.elegans protein (Agrin_LamG1_C.elegans) was used as a query against 
Swissprot, Trembl and Refseq databases. After the analysis of a more extensive alignment, the best hits 
were selected for this representation and include: the predicted agrin orthologue of C. briggsae 
(Agrin_LamG1_C.briggsae), the agrin LamG2 domains of the human, electric ray and chicken proteins, the 
LamG2 and LamG1 of human perlecan and the LamG4 of a laminin-like protein 2 (LAML2) identified in C. 
elegans.  The similarities between each of the sequences compared to the C. elegans lamG1 are expressed as 
% identity / % similarity.  
B.  The second LamG domain of the C.elegans protein (Agrin_LamG2_C.elegans) was used as a query 
against Swissprot, Trembl and Refseq databases. After the analysis of a more extensive alignment, the best 
hits were selected for this representation and include: the predicted agrin orthologue of C. briggsae 
(Agrin_LamG2_C.briggsae), the LamG4 of human lamininA4, the LamG3 of human perlecan and the agrin 
LamG3 domains of the human, electric ray and chicken proteins. The similarities between each of the 
sequences compared to the C. elegans lamG1 are expressed as % identity / % similarity. 
C. The C.elegans agrin sequence aligns best with the B0/z0 isoforms of chick and rat agrin, respectively. The 
conserved alternatively spliced agrin exons, encoding 8 aa, 11 aa or 19 aa inserts, at this site do not exist in 
C. elegans. 
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Fig. 5. Agr-1::reporter expression in transgenic animals. A, Reporter genes were fused to different 
portions of agrin non-coding and coding sequence as shown below the schematic representation of the 
genomic region containing the agr-1 promoter and agr-1 5’-end. The lengths of the promoter or gene 
sequences and the names of the the pagr-1::reporter plasmids and DNA arrays are indicated. Since all of 
these constructs resulted in the same expression patterns, representative micrographs of the kdIs66 
transgenic worms are shown in B-I. B and C, small groups of cells express GFP under the agr-1 promoter 
in early gastrula (≈100 min). D and E, expression in the anterior body of a late gastrula (≈240 min); no 
expression is visible in the tail (asterisk) of the animal. F and G, head of a young adult worm; expression in 
the buccal epithelial cells (dashed arrows) and in the IL1v and IL1d neurons (arrows); open arrowheads 
point at the IL1 processes in the nerve ring. H, L1 larval stage; expression in the buccal epithelial cells and 
other non identified cells near the pharynx (dashed arrow), IL1v and IL1d neurons (arrow) and posterior gut 
cells (asterisk). I, L2 larva; expression in the migrating distal tip cells (arrows) and posterior gut (asterisk).  
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Fig. 6. Agr-1 expression in IL1d and IL1v neurons. A-C, DiI staining in hdEx25 trangenic worms; no co-
staining is observed between agr-1::YFP (A) and DiI (B). D-F, no costaining is observed between agr-
1::GFP (D) and DiI + CaAcetate (E) in kdIs66 transgenic animals. G-I, costaining is observed in eat-
4::GFP (G) and agr-1::dsRED (H) in adIs1240; kdEx71 transgenic worms. (C, F, I) merged channels. In 
all panels dashed arrows point out dendrites; arrows neuronal cell bodies; arrowheads buccal epithelial cells 
and asterisks the nerve ring. 
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Fig. 7. Antibodies against C. elegans agrin. A. Schematic representation of the recombinant fragments 
used as antigen to raise monoclonal and polyclonal antibodies. For eukaryotic expression  the C-terminal 
lamG domains were fused to a short fragment of chicken tenascin C (Tn-C), including a secretion signal and 
the epitope of anti-Tn60. The specificity of both polyclonal and monoclonal antibodies was tested by 
western blotting on conditioned medium of COS cells transfected with the construct encoding the two 
LamG domains with the Tn-C-tag (B). Lanes 1 and 2 were incubated with polyclonal antisera from two 
different rabbits, respectively; lane 3 with the monoclonal antibody pool raised against the bacterially 
expressed fragment, and lane 4 with pre-immune serum. All antibodies detected a band of about 80 kDa, 
which corresponds to the size of the recombinant protein. Additional smaller bands (asterisk) most likely 
correspond to degradation products which are not recognized by the monoclonal antibodies. C-J, 
Immunofluorescence staining of transfected COS cells was performed with the anti-agrin monoclonal 
antibody pool (C-F) and compared to the anti-Tn60 control (G-J). In transfected cells (C and D; G and H) 
the secreted agrin fragment was detected on cell surfaces of non-permeabilized cells (C and G) or in the 
endoplasmatic reticulum / Golgi apparatus of permeabilized cells (D and H). Non-transfected cells were 
used as a negative control (E and F; I and J).  
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Fig. 8. Detection of endogenous C. elegans agrin by western blot and immunofluorescence. Lysates of 
wild type (N2) and agrin mutant worms (eg1770, eg153, tm2051) were analysed on western blots A. Two 
prominent bands of about 160 kDa and 75 kDa were present exclusively in the wild type (wt) worms and 
not the mutants. The larger band corresponds to the calculated size of the full length AGR-1 protein and the 
smaller band may represent an agrin degradation product. Asterisks denote two additional background bands 
present in all the strains. (B) Worms were immunostained with the monoclonal antibody pool against C. 
elegans agrin (green) and Rim, a synaptic marker prominent in nerve ring (red). Agrin was detected in the 
basal lamina around the pharynx procorpus (arrow) and anterior bulb (asterisk). Posterior bulb staining was 
weaker possibly due to poor antibody penetration (dashed arrow). (C-H) Polyclonal antiserum staining 
resulted in the same pattern in the pharynx of wild type worms (C and D, asterisk for anterior bulb) where it 
was clearly absent in agrin mutants (F-H). Prominent background staining of the gut was present in all 
strains (C-H, arrowhead). Preimmune serum of the same rabbit was used as negative control on wild type 
worms (E) where both pharyngeal and gut staining was clearly missing. 
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Fig. 9. In vitro interaction between C. elegans agrin and vertebrate α-dystroglycan. Purified chicken α-
DG was transferred to nitrocellulose membrane after separation by SDS-PAGE and membrane strips were 
incubated with different samples of agrin: lane 1, chicken muscle agrin isoform; lane 2, chicken neuronal 
isoform; lane 3, C. elegans agrin in conditioned medium of transfected COS cells; lane 4, conditioned 
medium of non-transfected COS cells. Binding of the respective agrins was detected by anti-chick agrin 
antibody (lanes 1 and 2) or with the anti-Tn60 antibody raised against the short tenascin C fragment which 
was fused to the C.elegans agrin fragment (lanes 3 and 4). Binding of C.elegans agrin to α-DG was detected 
in lane 3, but not in the negative control (lane 4). 
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Fig. 10. Recombinant C. elegans agrin clusters endogenous dystroglycan in COS cells. 
 
COS cells were transfected with the recombinant fragment of C. elegans agrin and immunostained for agrin 
and endogenous β-DG. (A-F) In transfected cells, agrin secreted into the medium bound to the cell surface 
in a patchy pattern (A and D, arrows). The cells were co-immunostained for endogenous β-DG (B and E) 
which, in transfected permeabilized cells, colocalized with agrin (F, arrow). Weak β-DG staining in non-
peremabilized cells (A-C) is probably due to minor antibody diffusion into cells. In non-transfected cells (G 
- L), no agrin staining was present (G and J) and β-DG showed diffuse, homogeneous membrane staining  
(H and K).  
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Table 1. Primer sequences  
 
 
 
Primer name Sequence (5’ ? 3’ direction) 
 
agr 1 
agr 2 
agr 3 
agr 6 
agr 9 
agr 12 
agr 25 
agr/TN (antisense) 
E32 
E33 
E34 
E35 
E36 
E37 
E149 
E150 
lam 3 
lam 6  
lam 8 
lam 8 euk 4    
oligo dT (for 3’UTR) 
overlap5’ agr (sense) 
T3 primer  
XY1 
XY2 
 
 
TGATGAAGCTGGAAGTCCCTGTGAG 
AATTCCCAGATGACTTTTCCAGCC 
ACGCGCATTGGCACCTTTCTC 
TGGGCATACACATTTGGGTTTTCCG 
GCCTCCATCTCATTGTCATTCATC 
TCGGATTGGCTCCTCCAAGATATAC 
GCAAGAAGGAGCATGGAGTCAG 
GAAATTTCAGGCGCCATGGAGCAGTTGGGGCCTTTC  
AAGCATGCGGAGTTGAGTGGAGACGC 
AACTCTAGAGCGGCCGCAAGATCGATGTGAAGTCTCATGTCGAC 
CACATCGATCCTCGTCCAACTCGTTCC 
TAGAGCGGCCGCTTCATTATCAAAAGTCTCTCC 
AAATCGATATGAGTAAAGGAGAAGAAC 
TTATCGATCTAGGCGCCTTTGTATAGTTCATCCATGCC 
TTGGTACCGCATGCCCGAGAGGAGTACGCGTCC 
TTGAGCTCAGTCGACTGCAGCATGGCGACATGTGAAAGTGAAAATG 
GAAGCATGCATGGCGCCTGAAATTTCAAGAAC 
GTGAAGCTTAGATATCAAATTGATTGGAAGT 
GTGAAGCTTTTAGTTATAGCAGTACTTGGGT 
CAGCGGCCGCCATCTAGATTAGTTATAGCAGTACTTGGG 
GGCATGGTT(TTT)6 
ATGGCGCCTGAAATTTCAAG 
TTAATTGGGAGTGATTTCCC 
GCCTGCAGTGTTATGAATTTTTCTTGAG 
CCTCTAGATGAAAGTGAAAATGTTTCGTTTC 
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III.2. Unpublished Results  
 
III.2.1. Expression and purification of recombinant C.elegans agrin fragments 
 
With the goal to raise anti-agrin monoclonal antibodies and for the in vitro assays, we cloned the first 
laminin G domain of C. elegans agrin (see section III.1.) 
Following expression in E. coli, the protein lysates were solubilized in denaturing buffer (prepared 
following the QiaExpressionist protocol, Qiagen) and the agrin fragment was purified over Ni-NTA agarose 
beads packed in a column. The interaction between the agrin fragment and Ni+ ions on the column material 
was due to the six-histidine tag fused to agrin. Following extensive washing, the 25 kDa agrin fragment was 
eluted from the column by decreasing pH (Results, Fig. 11). Only odd-numbered fractions were loaded on 
the SDS PAGE and detected by Coomassie blue staining. The fractions richest in agrin fragment (C8 to D3) 
were pooled and dialysed against PBS- before they were injected into mice to raise monoclonal antibodies. 
 
 
 
Fig 11. SDS PAGE of the protein lysates and of the fractions eluted from the Ni-NTA agarose column, and 
purification of the recombinant agrin fragment comprising the first lam G domain 
 
A second recombinant worm agrin fragment composed of both lam G domains (2LamG) was fused to a 
short fragment of chicken tenascin C coding for a secretion signal and an oligomerization domain (Results, 
Fig. 12). The cloning and expression procedure is explained in detail in the chapter containing Submitted 
manuscript.  
HEK293EBNA cells were transfected with the 2lamG construct and Puromycin resistance served to select the 
transfected cells. The expression of the agrin fragment 2lamG was detected in the conditioned medium by 
western blot with an anti-TN-C epitope antibodies (Results, Fig. 12A). In order to additionally confirm the 
correct cloning, we analyzed the conditioned media containing the recombinant fragment, by reducing and 
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non-reducing conditions. The presence of the TN-C oligomerization domains caused the formation of 
protein hexamers which were intact under non-reducing conditions (SB-) and disrupted in reducing 
conditions (SB+) (Results, Fig. 12B). Conditioned media from the cell line, stably expressing the agrin 
fragment, were concentrated and the fragment was purified over an affinity column containing anti-TN-C 
antibody. The purified fragment was further used for raising polyclonal antibodies and for in vitro assays. 
 
 
 
Fig 12. A, western blot of the conditioned media from HEK293EBNA cells, either non-transfected (negative 
control, 0), transiently transfected with the clone called 9D or a stably transfected cell line selected by 
resisitance to the antibiotic puromycine (Pu). B, western blot of conditioned media prepared for the gel in 
non-reducing (SB-) and reducing (SB+) conditions. Oligomerization happens due to the short fragment of 
TN-C fused to the agrin 2LamG fragment. 
 
 
III.2.2. Detection of the endogenous C. elegans agrin by immunofluorescence 
 
[This part was done in collaboration with Gordon Lau, an IAESTE student in our laboratory.] 
As one of the first steps towards understanding agrin function in C. elegans, we extensively analysed its 
localization by immunofluorescence. In order to set up the staining protocol, we optimized the staining 
conditions for previously described markers (Results, Fig. 13). Antibodies against the presynaptic vesicle 
marker Rim [153], kindly provided to us by Prof. Michael Nonet, stained the nerve ring and most of the 
neurons in the worms’ bodies (Fig. 13A). Furthermore, we used antibodies against prominent muscle and 
basement membrane proteins, the anti-myosin monoclonal antibody 5-6 [177] (Fig. 13B) and the anti-
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perlecan monoclonal antibody MH2 [104] (Fig. 13C), both obtained from the Developmental Studies 
Hybridoma Bank, University of Iowa in Iowa City. Those proteins served as markers to investigate the 
morphology and structural integrity of the corresponding tissues in agrin mutants. No difference was 
observed between the staining of wild type and agrin mutants agr-1(eg1770) worms suggesting that nerve, 
muscle and basement membrane structure was not impaired due to agrin loss (results not shown). 
 
 
 
Fig 13. Immunostaining of wild type worms for the pan-neuronal marker Rim (A, arrow points to the nerve 
ring), the muscle marker myosin (B, arrows point to body wall muscles and the asterisk shows the position 
of the vulva), and perlecan for basement membrane (C). 
 
The immunostaining procedure is based on the “Finney & Ruvkun protocol” (see section III.1.) [176]. For 
high-resolution visualization of the staining, we analyzed the samples by confocal microscopy. Most 
prominent immunostaining was observed in the pharynx of the worms (Results, Fig. 14). Agrin was detected 
primarily in the basement membrane of the pharynx (Fig. 14) and the marginal cells (Results, Fig. 15). This 
protein localization led us to further investigate pharynx function and morphology in the agrin mutants, as it 
is explained in a later paragraph.  
Beside pharynx, some immunostaining was detected along the dorsal and ventral nerve cords, in the area of 
hypodermal ridges, a thickenings of the hypodermis (Fig. 16) known to be involved in axon guidance and 
neuronal patterning along the midline [100]. It is important to mention that, to some extent, agrin 
immunostaining was also present in the hypodermal ridges in the agrin mutant agr-1(eg1770), suggesting 
that the staining might not be specific. 
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Fig 14. Immunostaining of the wild type worm with the pool of anti-agrin monoclonal antibodies (green) 
and anti-Rim antibodies, (red, pre-synaptyc neuronal marker). Arrow points to the pharynx procorpus, 
asterisks label the first and second pharyngeal bulb, dashed arrow points to a subset of head neurons, full 
arrowhead shows the mouth of the worm (including the labial sensilla of IL1 neurons), and empty 
arrowhead points at buccal hypodermis. Red staining of Rim protein localizes mainly to the nerve ring. 
 
 
Fig 15. Immunostaining of marginal cells in the pharynx. A, Marginal cells are stained in green, mostly in 
the anterior part of the pharynx, probably due to better antibody penetration. B, Schematic representation of 
the main components of the pharynx with marginal cells shown in purple. C, Lateral view if the anti-agrin 
immunostaining presented in false colors for better visualization. D, Transverse view of the false-coloured 
agrin immunostaining. E, Schematic transverse view of the pharynx. (B and E were adapted from 
www.wormatlas.org) 
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Fig 16. Agrin immunostaining (green) in the area of hypodermal ridges follows dorsal and ventral nerve 
cord (stained red for presynaptic protein Rim). 
 
 
III.2.3. Assays in vitro with recombinant C. elegans agrin fragment 2LamG 
 
[Materials & protocols for these experiments were kindly provided by Prof. Markus A. Rüegg, University 
of Basel] 
 
 III.2.3.1. AChR clustering on muscle myotubes in vitro 
In vertebrates agrin has a prominent function at the neuromuscular junction where it contributes to the 
clustering of AChRs and their maintenance (reviewed in [13]). The clustering activity was demonstrated by 
in vitro assays on cultured muscle myotubes [178] [2]. Based on described properties of vertebrate agrin, we 
investigated whether the C. elegans 2LamG (see above) agrin fragment, comprised of the two C-terminal 
lam G domains, retains the clustering activity on muscle myotubes.  
We performed the experiment following the standard protocol from the Rüegg lab. The procedure is 
explained in the Appendix. Tissue culture dishes were coated with gelatin and mouse muscle precursor cells 
(myoblasts, C2C12 line) were grown until about 80% confluency (Fig. 17). Differentiation of the cells was 
induced by the exchange of fetal calf serum for horse serum at a lower concentration. Under these 
conditions, the cells were cultured during 5 days and by the end of that time the muscle precursor cells had 
fused into syncytial myotubes (Fig. 17).  
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Fig 17. Differentiation of muscle C2C12 myoblasts into muscle myotubes. Syncytial organization is clearly 
visible in differentiated muscle cells. 
 
The cultures were incubated with recombinant 2LamG fragment of C. elegans agrin. Chick agrin fragments, 
composed of all three lam G domains, served as controls. A neuronal isoform, which contains inserts at the 
B+/z+ site was used as positive control, while the muscle isoform, lacking the inserts (B-/z-), served as 
negative control. After an overnight incubation, cells were rinsed, fixed and stained for the AChRs subunits 
by fluorescently labeled bungarotoxin (Btx), toxin which irreversibly binds to the receptor subunits. Many 
AChRs clusters were present on the myotubes incubated with the chicken neuronal agrin fragment, no 
clusters were present on the myotubes following the incubation with the muscle agrin fragment, and only 
some were induced by the C. elegans 2LamG agrin fragment (Fig. 18). 
Since the concentration of C. elegans agrin was more than 100 times higher than the controls, and yet did 
not give significant clustering, we could conclude that C. elegans agrin does not actively cluster AChRs on 
vertebrate muscle fibers. In vivo expression pattern data together with the behavioral analysis of agrin 
mutants do not support its function at the NMJ. Therefore, we could conclude that AChR clustering at the 
NMJ in C. elegans probably does not depend on agrin. 
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Fig 18. In vitro AChRs clustering assay on differentiated muscle myotubes. Clustered receptors were 
visualized by rhodamine-labelled bungarotoxin (Btx). A-C, Neuronal agrin served as positive control (at 
concentration 1 ng/µl) and the induced clusters can clearly be seen. D-F, Muscle agrin did not show 
clustering activity. G-I, Recombinant fragment of C. elegans agrin did not show a significant clustering 
activity, although some clusters could be detected (at concentration 125 ng/µl) (I). 
 
 
 III.2.3.2. Affinity chromatography experiments with C. elegans agrin fragment and worm 
 lysates 
 
[These experiments were carried out in collaboration with Marianne Brown-Lüdi, research associate in 
our laboratory] 
With the objective to identify interacting partners of C. elegans agrin we analyzed proteins that bind to the 
2LamG agrin recombinant fragment (see above). The purified 2LamG fragment was bound to CNBr-
activated Sepharose beads and packed into a column following supplier’s protocol (see Appendix). Worm 
lysates were prepared from large amounts of frozen worms and, after protein extraction the soluble fractions 
were passed over the affinity column. Following extensive washing, the proteins which interacted with agrin 
on the column, were eluted and the fractions analyzed by SDS PAGE followed by mass spectrometry (Fig. 
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19). An empty column, containing only CNBr-activated beads, served as a negative control. Several proteins 
did bind to the agrin column. Among them there were putative oxido-reductase metabolic enzymes involved 
in fatty acid oxidation (Q9BIC3_CAEEL and Q9GYT0_CAEEL) and YKA3_CAEEL from the thiolase 
family. A small quantity of a few known proteins was detected e.g. vitellogenin-6 (Q7KPP7_CAEEL), 
histone-4 (H4_CAEEL), and actin protein 4 isoform c (Q6A8K1_CAEEL). There was no clear connection 
between agrin and the identified proteins, therefore we did not consider the interactions specific and 
meaningful. Surprisingly, despite previously demonstrated interactions between agrin and α-dystroglycan 
(see Submitted manuscript), we could not confirm this by the affinity column experiment. A possible 
explanation is that dystroglycan is not soluble under the extraction conditions we used. 
 
 
Fig 19. Putative agrin interacting partners were analyzed by affinity chromatography. The experiment was 
repeated three times with different buffers and conditions (A, B, C) and the proteins, which were selectively 
eluted only from the agrin column, were analyzed by mass-spectrometry. 
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III.2.4. Studies of agrin in vivo function in C. elegans 
[The “in vivo” analysis was carried out in collaboration with Dr. Stefano Canevascini, post-doc in the 
laboratory] 
 III.2.4.1. Investigating possible agrin function at the NMJ  
 III.2.4.1.A. Pharmacological assays with levamisole and aldicarb 
Based on the previously described and very well known agrin function at the NMJ (reviewed in [13]), we 
searched for similar functions in C. elegans. None of the agrin mutants, i.e. agr-1(eg1770), agr-1(eg153), 
agr-1(tm2051), showed any locomotory defects that could be linked to defective NMJs. We have therefore 
used different pharmacological approaches to reveal possible agrin function at the synapse, and comparing 
the agrin mutants to the wild type worms.  
Levamisole and aldicarb are nematocide drugs commonly used for this kind of experiments. Levamisole is 
an AChR agonist, which irreversibly binds to some of the receptor subunits and causes toxicity leading to 
the paralysis and death of wild type worms [86] [111]. Mutants with defects in AChR subunits or loss of 
receptor clustering at NMJ do not respond in this way and appear resistant to the drug, e.g. lev-1(e211) 
which we have used as a negative control. We tested agrin mutants for resistance to levamisole (Sigma) 
following a standard procedure (see Appendix - Experimental procedures). The agrin mutant agr-1(eg1770) 
showed a very weak resistance to the drug at low concentrations of 0.25mM, but not at a concentration of 
0.5mM (Fig. 20). Taken together the fact that only a very low concentration of levamisole is tolerated and 
that the standard deviation values were high in our experiments, we could not claim that agrin plays an 
important role at the synapse.  
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Fig 20. Levamisole resistance assays on agr-1(eg1770) worms at three different concentrations of the drug. 
A, schematic genomic representation of the eg1770 agrin mutant, a Mos1 transposon is inserted in the agrin 
ORF. B, Agrin mutant shows a very weak resistance to 0.25mM levamisole, but not o 0.5mM levamisole. 
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In parallel with the levamisole assays, we have used aldicarb (ChemService) with the same goal. Aldicarb is 
an antagonist of acetylcholine-esterase (AChE), the enzyme that metabolizes ACh from synaptic cleft [88]. 
Under normal physiological situations, AChE removes the neurotransmitter and prevents its accumulation in 
the synapse after the signal is received by the muscle membrane. Aldicarb binds to the enzyme, thus 
preventing it from degrading ACh, which then over-accumulates in the synaptic cleft and causes toxicity, 
paralysis, and death. Many mutants with presynaptic (neuronal) and postsynaptic receptor defects exhibit 
resistance to aldicarb.  
With the assumption that agrin might play a role in either of these NMJ aspects, we treated agr-1(eg1770) 
mutants with aldicarb and scored their viability (see Appendix - Experimental procedures). In addition to the 
single agrin mutation alone, we tested agrin triple mutants with dystrophin dys-1(cx18) and dystrobrevin 
dyb-1(cx36), mutants that alone display hypersensitivity to ACh and aldicarb [147] [148]. Wild type and 
agr-1(eg1770) single mutant worms showed the same time-dependent sensitivity to aldicarb (Fig. 21). The 
dystrophin, dystrobrevin double mutant showed the expected hypersensitivity to the drug, while in 
combination with the agrin mutation the animals seemed more resistant. This result showed that absence of 
agrin “rescued” dys-1 dyb-1 hypersensitivity, but due to the high standard deviations, it could not be 
concluded that AGR-1 definitely has a NMJ function. The experiment would have to be repeated on a larger 
sample by the genotype-blinded experimenter to avoid bias.  
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Fig 21. In vivo pharmacological assays on C. elegans with the AChE inhibitor aldicarb. Wild type, agr-
1(eg1770), dys-1(cx18) dyb-1(cx36) double mutants, and dys-1(cx18) dyb-1(cx36); agr-1(eg1770) triple 
mutants were tested on 0.2mM aldicarb. Agrin loss rescues aldicarb hypersensitivity of the dys-1(cx18) dyb-
1(cx36) double mutants. 
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III.2.4.1.B. Investigating possible agrin genetic interactions with acetycholine esterases (AChE)  
 
In addition to pharmacological experiments towards elucidating possible agrin function at the NMJ, we 
undertook a genetic approach with the same goal. Since agrin mutants on their own did not display an 
obvious phenotype, we investigated possible genetic interactions in sensitized backgrounds. We chose to 
work with acetylcholine esterase (AChE) mutants. AChEs metabolize ACh at the synapse. There are four 
AChE genes in C. elegans but ace-1 and ace-2 exhibit 95% of the total esterase activity [179]. The ace-1; 
ace-2 double mutant has an obvious uncoordinated phenotype due to the accumulation of ACh at the NMJs 
and concomitant toxicity. Our working hypothesis was the following: if agrin in C. elegans is involved in 
AChRs clustering in the worm, when mutated in the ace-1; ace-2 background, it should rescue their unc 
phenotype, by reducing toxic signaling caused by the elevated ACh levels (Fig. 22). 
 
 
 
Fig 22.  Schematic model of our working hypothesis that served as basis for genetic experiments with agr-1 
and ace-1; ace-2 mutants. In case agrin in the worm had a function at the NMJ, we would expect it to rescue 
the unc phenotype of ace-1;ace-2 mutants. 
 
 
We crossed the agr-1(eg1770) mutant with the double mutant for the AChE genes ace-1(p1000); ace-2(g72), 
thus creating a triple mutant for three genes possibly interacting at the synapse. Cross progeny of the first 
generation (F1) was heterozygous for all genes and the following generations had to be genotyped. Since the 
mutants carried different types of mutations, we applied different genotyping methods (Fig. 23), e.g. ace-1 
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had a point mutation which altered an existing restriction site and could be detected by restriction analysis 
of the PCR product that included the mutated nucleotide. As a result, mutant DNA subjected to BslI 
digestion was not cleaved while the wild type was cut in two fragments (Fig 24). The worm cloning 
procedure, lysis, and PCR are described in detail in the Appendix of the Thesis. 
 
 
 
Fig 23. Mutants in agr-1 and ace genes carry different types of mutations and therefore require specific 
screening approaches. The agarose gel in the lower panel shows, as an example, the controls for ace-1 gene 
screening by PCR followed by digestion with BslI. 
 
Since double mutants ace-1;ace-2 had an unc phenotype, they could easily be identified in the progeny. Unc 
and non-unc animals of the third generation (F3) were cloned and after having layed eggs the hermaphrodite 
parents were analysed by PCR for all three genes (Fig. 24). In case of ace-1, PCR was followed by BslI 
digestion and for ace-2 by sequencing to confirm the point mutations. Agr-1(eg1770) was screened by PCR 
that distinguished between the wt and the mutant allele carrying the insertion of the Mos transposon. The 
screening procedures are described in the Appendix. All F3 lines of unc animals were confirmed to be agr-1; 
ace-1; ace2 homozygous mutants (Fig. 24A). Out of 9 tested non-unc animals, seven were heterozygous for 
both ace-1 and ace-2, two were homozygous mutant for agr-1 and ace-1, but the sequencing showed that 
these last two animals were heterozygous for ace-2 (Fig. 24B, lines 2 & 4). The fact that the agrin mutation 
did not rescue the unc phenotype of the ace-1; ace-2 worms suggests that agrin does not have an obvious 
function in clustering AChRs at NMJ. 
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Fig 24. Genotyping of mutant uncoordinated (unc) and coordinated (non-unc) worms in the agr-1 cross with 
ace-1;ace-2. Uncoordinated (unc) animals were homozygous mutants for all the genes, but non-unc were 
either homozygous mutants (0/0) for ace-1 and heterozygotes (0/+) for ace-2 (lines 2 & 4), or heterozygous 
for both ace-1 and ace-2. 
 
 
 III.2.4.2. Analysis of putative agrin function in C. elegans muscle 
 
 III.2.4.2.A. Genetic approach to test possible agrin interactions with components of the 
 dystrophin-glycoprotein complex (DGC) 
In vertebrates agrin expressed by skeletal muscles and binds to α-dystroglycan as part of a large dystrophin 
glycoprotein complex (DGC), reviewed in [13]. It was shown that an agrin mini-gene consisting of the 
secretion signal, laminin-binding NtA domain, first follistatin-like domain, and the C-terminal three lamG 
domains, can rescue the dystrophic phenotype of laminin α2-deficient mice by linking basement membrane 
to α-dystroglycan [66]. Based on the described function in vertebrates, we considered potentially similar 
role in C. elegans. Despite the fact that we did not detect any agrin expression in the body wall muscles, 
neither by reporter fusion analysis nor by immunofluorescence, undetectable levels could still be present 
and interact with other DGC components.  
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Fig 25. Schematic representation of the dystrophin-glycoprotein complex (DGC) and related proteins.  
Many muscular dystrophies are caused by mutations in these proteins (left panel). The right panel lists all 
the mutants and RNAi experiments we have used to investigate possible genetic interactions between agrin 
and known muscle-related proteins involved in providing muscular integrity. 
 
We have created many double mutants with agrin and different components of the DGC (Fig 25). In 
addition, we knocked down agrin, by double stranded RNAi (dsRNAi), in perlecan unc-52(gk3), dig-
1(n1321)(dig = displaced gonad), and agrin mutant backgrounds agr-1(eg1770). The procedure of dsRNA 
production and the “knock-down” experiment are explained in the Appendix. 
Our rationale was that, if the tested genes had functional interactions, the combined loss would cause 
stronger defects. Therefore, we investigated possible morphological or behavioral defects, in double mutants 
and the dsRNA treated “knock-down” worms. We looked at muscle integrity by anti-myosin 
immunostaining, observed locomotion and viability, but could not detect any aggravated defects when 
compared to the single-gene mutants. Therefore, we could conclude that C. elegans agrin does not play a 
role in muscle function and stability. 
 
 
 
 
 78 
 
Unpublished Results 
 III.2.4.2.B. Addressing possible genetic interaction between agrin and dystroglycan in  
 C. elegans 
 
In C. elegans three genes encode dystroglycan-like proteins: dgn-1, dgn-2, and dgn-3 [158]. In terms of 
sequence and structural organization, dgn-1 shares the highest similarity to the vertebrate protein. 
Nevertheless, there are significant differences to the vertebrates: firstly, dgn-1 is not post-translationally 
cleaved into α and β subunits and the expression pattern seems to be quite different. No dgn-1 expression 
was detected in body wall muscles. Dgn-2 and dgn-3 are expressed in a few neural and epithelial cells and 
null mutants in these genes do not show significant defects (James Kramer, unpublished results). The dgn-1 
gene is mostly expressed in the epithelia and some neurons and the mutant is sterile due to severe defects in 
gonad development.  
We have previously demonstrated that a recombinant fragment of C. elegans agrin can bind to vertebrate 
dystroglycan (see section III.1. Submitted manuscript). Based on this result we decided to investigate 
possible genetic interaction between the two proteins. We crossed the agr-1(eg1770) mutant with either the 
triple mutant dgn-1(cg121) dgn-2(ok209) dgn-3(tm1092) or with the double mutant dgn-2(ok209) dgn-
3(tm1092), kindly provided to us by Prof. James Kramer, Northwestern University, Chicago. Since the triple 
mutant dgn-1(cg121) dgn-2(ok209) dgn-3(tm1092) is sterile, it was balanced by a wild type copy of the 
gene on an extrachromosomal array cgEx308[dgn1(+), dgn-1::GFP, pRF4] together with copies of gfp 
expressed under the control of the dgn-1 promoter, and the rol-6mut gene (pRF4) that causes a roller 
phenotype. 
The strategy for the crosses is presented in the Fig 26 and Fig 29. At the beginning of both crosses agr-
1(eg1770) males were crossed with dgn mutant hermaphrodites. Several worms from the progeny of each 
generation were cloned, let to lay eggs, and genotyped by PCR. The detailed protocols are found in the 
Appendix.  
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Fig 26.  Scheme showing the strategy for the isolation of the quadruple mutant agr-1(eg1770); dgn-1(cg121) 
dgn-2(ok209) dgn-3(tm1092). 
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Since the triple mutant dgn-1(cg121) dgn-2(ok209) dgn-3(tm1092) had to be rescued by a wild type dgn-1 
copy of the gene on an extrachromosomal array, the wild type gene was always amplified by PCR, therefore 
adding to the screening complexity. Since only the rescued animals (carrying the extrachromosomal array) 
could have progeny, we had to select them and clone the GFP-expressing rollers. The dgn-1 deletion allele 
could be detected as a shorter band by PCR, but a large band, due to the wild type copy of dgn-1 from the 
rescuing array, was always present on the agarose gel, making it impossible to distinguish between 
heterozygous animals and homozygous mutants which have the array. The final mutant lines were 
genotyped for all four genes (Fig. 27), and their non-rescued (non-green, non-rolling) progeny analysed for 
the dgn-1 gene to avoid the confusion with extrachromosomal array (Fig. 28). 
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Fig 27.  Final confirmation of the quadruple mutants agr-1(eg1770); dgn-1(cg121) dgn-2(ok209) dgn-
3(tm1092). “+” is the wild type control, “0” is the mutant positive control, and 1-4 are four independent 
lines of quadruple mutants. Asterisk denotes the wild type dgn-1 band of almost 3000 bp. (Lanes with the 
same numbers correspond to the same worm lysed and genotyped) 
 
 
 
 
Fig 28. PCR of 20 cloned non-rolling worms agr-1(eg1770); dgn-1(cg121) dgn-2(ok209) dgn-3(tm1092). 
None of the worms without extrachromosomal array had a wild type copy of the gene therefore they were 
all homozygous mutants for dgn-1(cg121). 
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Fig 29. Scheme of the genotyping strategy for the agr-1(eg1770) cross with dgn-2(ok209) dgn-3(tm1092) 
 
 
 
 
 
Fig 30.   Final confirmation of the triple mutants agr-1(eg1770); dgn-2(ok209) dgn-3(tm1092). “+” is the 
wild type control, “0” is mutant positive control, and 1-6 are six independent lines of triple mutants. 
 
 
The successful cross between agr-1(eg1770) and dgn-2(ok209) dgn-3(tm1092) was confirmed by PCR for 
all the three genes from the same worms (Fig. 30). Dgn-2 and dgn-3 are primarily expressed in the pharynx 
of the worms, but without any significant impairment in the mutants (J. Kramer, unpublished data). We 
expected that the triple mutant with agr-1 might cause some visible defects in pharynx morphology or 
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function, in case they genetically interact. To our disappointment no obvious phenotype could be observed 
in the triple mutant strain. 
 
 III.2.4.3. Testing a possible role of agrin in pharynx-related functions 
 
 III.2.4.3.A. Pumping phenotype 
The pharynx is a muscular pump important for ingesting food, and transporting it to the gut of the worm. 
Based on specific agrin immunostaining in the basal lamina of the pharynx, which was selectively absent in 
the agrin mutants, we hypothesized that agrin could have a pharynx-related function.  
We chose to look at the pharynx pumping-rate and morphology and to follow them through the aging 
process (young to old adult worms) to see whether differences could be detected between the wild type and 
the agrin mutants eg1770, eg153 and tm2051 (Fig. 31) [120]. Based on a recent report [171], we expected 
that if agrin mutant had a lower pumping rate, pharyngeal morphology would be better preserved as the 
worms get older. In our experiments we did not observe any significant difference neither in the pumping 
rate (Fig. 30) nor in pharynx morphology (results not shown) between the wild type and the mutant worms.  
 
 
 
Fig 31. Pharyngeal pumping experiment. The wild type worms (N2 strain) and three agrin mutants (eg1770, 
eg153 and tm2051) (n=50) were followed during 10 days and the pumping-rate was measured at 5 day-
intervals. 
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III.2.4.3.B. Feeding phenotype – large bacteria 
 
It was reported previously that large-sized bacterial strains  are eaten less efficiently by worms [120]. 
Therefore, we tested whether agrin mutants showed any difference in growth rate when fed with the large-
sized bacterial strain Bacillus megatherium as compared to the E. coli strain commonly used for feeding 
(Fig. 32). The Bacillus megaterium strain was kindly provided to us by the Bacillus Genetic Stock Centre, 
Dept. of Biochemistry, Ohio State University. 
 
 
Fig 32. Bacterial strains used for C. elegans feeding experiment. White arrows show the bacteria and orange 
arrowheads point to the impurities on the specimen. 
 
The experiment was done following the protocol in the publication by Avery et al [120]. Starved 
synchronized L1 worms were grown on lawns of the two bacterial strains at 18°C and observed every 1-3 
hours until approximately 50% of the animals reached the adult stage. The inverse of time (in days) it took 
hermaphrodites to become adults was plotted as growth rate (Fig. 33). Adults were recognized by the 
appearance of a mature vulva, and by the production of eggs.  
There was no significant difference in growth rates of agrin mutants fed on the two different bacterial strains, 
except for a slight difference between agr-1(eg1770) and wild type on the E. coli. Worm strains eat-4(ky5) 
and eat-5(ad464) served as positive control and showed greater sensitivity to large the bacterial strain as 
observed by their slower growth rate. 
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Fig 33. Growth rate of worms fed on two different bacterial strains: E. coli or B. megaterium. N2 is the wild 
type; eg1770, eg153, and tm2051 are agrin mutants; eat-4(ky5) and eat-5(ad464) are strains that served as 
positive control. 
 
 
 III.2.4.4. Search for phenotypes related to IL1 head neurons 
 
We found agrin expression in the worm only in four head neurons and some pharyngeal cells, by reporter 
gene fusions. The four neurons were identified as the mechanosensory IL1 neurons, based on their structure, 
also suggested to carry out interneuron and motor neuron functions [98], (Driscoll M & Kaplan J, chapter in 
[88]). There are in total six IL1 neurons, distributed in three pairs: dorsal, lateral, and ventral [93], but, 
interestingly, agrin seems to be expressed only in the dorsal and ventral pairs. IL1 neurons mediate an 
aversive head-withdrawal reflex when worms are touched on either the dorsal or ventral sides of their nose 
[98]. The laboratory experiment is usually done with an eyelash and is commonly called the “eyelash test” 
[88]. We tried to set up the “eyelash test” in our laboratory, but touching the small area of the nose of a 
1mm-long moving worm under the dissecting microscope tourned out to be too difficult and not 
satisfactorily reproducible. 
 
To investigate whether agrin has a function in IL1 neuron-mediated mechanosensation, we chose instead to 
perform a technically easier “nose touch” experiment. The experiment was done by putting an eyelash on 
the worms crawling path and scoring their avoidance of the obstacle when they collided with it. Agrin 
mutants agr-1(eg1770) were compared to wild type worms as a positive control. As negative controls we 
tested che-3(p801) mutants that have impaired perception of the light nose touch due to a mutation in dynein 
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heavy chain (DHC), 1b isoform, that affects the structural integrity of sensory cilia. In order to avoid the 
bias, the experimenter did not know the genotype of the tested strains during the experiment. Agrin mutant 
strains agr-1(eg1770) and agr-1(tm2051) were as sensitive to the stimulus as the wild type worms (Fig. 34), 
but the standard deviations were very high, probably due to the high degree of experimental mistakes.  
 
 
Fig 34. Nose-touch (Not) avoidance scored by the “nose touch” test. 
 
 
We were as well interested to see if loss of agrin had an impact on the morphology of IL1 neurons. With this 
goal we created transgenic strains expressing the YFP reporter under the control of the agrin promoter 
(Ex[agr-1::YFP]) in agr-1(eg1770) mutants (Fig. 35). Transgenic lines were analyzed by confocal 
microscopy (with falsely-coloured YFP as green) and did not display any noticeable dendritic defects. 
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Fig 35. Morphology of IL1  neurons in the wild type and the agr-1(eg1770) worms. Mos1 transposon is 
inserted in the agrin ORF. Full-line arrows point to the dendrites of IL1 neurons, dashed arrows show the 
axons in the nerve ring, and asterisks label the cell bodies. 
 
 
 III.2.4.5. Genetic approach to test possible agrin interactions with different signaling pathways 
 involved in gonad development 
 
Gonad development in C. elegans involves a precise combination of multiple guidance and signaling 
systems [88]. Distal tip cells (DTCs) are the “leading edge” of the developing gonad which sense 
environmental cues for proper pathfinding and thereby determine the gonad morphology. Impairment in 
several signaling mechanisms causes defective gonad migration which is easily visible under a microscope. 
The observation that agrin is expressed in the DTCs at the time of migration (see Submitted manuscript), 
prompted us investigate whether it may play an active role in this process. 
We took advantage of the powerful C. elegans model system for genetic studies. We investigated whether 
agrin has a significant impact on gonad migration and whether it can modulate the signaling pathways 
previously shown to play a role in this process. The approach and the strains used are based on a publication 
by the Culotti’s lab  [132]. All strains that we crossed with our agr-1(eg1770) strain were obtained from the 
Caenorhabditis Genetics Centre (CGC). The gonads were analyzed in the single mutant background and in 
double mutants. Defects were classified according to the morphology of the anterior and posterior arms, as 
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dorsalization, ventralization and various severe defects (Table 1). All defects were expressed as % of the 
total number of the gonads scored.  
 
 
Table 1. Gonad migration defects caused by mutations in several signaling pathways in combination with 
agr-1(eg1770). The most significant differences, due to agrin mutation in various backgrounds, are framed 
in red. 
 
 
 
We never observed differences higher than 15% between the single and the double mutants. Furthermore, in 
most cases where differences were observed the double mutants showed less defects. Since in this kind of 
experiment high variations are normal and a 15% difference is not considered significant [132]. Therefore, 
the results suggest that agrin does not play a major role in gonad migration in the worm. 
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 III.2.4.6. Axon guidance experiments 
 
[These experiments were done in collaboration with Dr. Christa Rhiner and Prof. Michael Hengartner, 
University of Zürich] 
Proteins expressed in the basement membrane of the hypodermal ridge are known to have axon guidance 
properties [180]. Based on our detection of agrin in the hypodermal ridge by immunofluorescence, we 
investigated potential agrin involvement in axon guidance in C. elegans, in collabolation with Christa 
Rhiner from Michael Hengartner’s lab in Zürich. Hengartner and collaborators have previously shown that 
the heparan sulphate proteoglycan syndecan plays a role in axon guidance in the worm [101]. They 
investigated transgenic worms expressing fluorescent markers in distinct subclasses of neurons. DD neurons 
are motoneurons and their cell bodies are distributed along the ventral nerve cord. In normal development 
the axons of DD neurons grow circumferentially and reach the dorsal nerve cord where they synapse to their 
targets. In syndecan sdn-1(zh20) mutants DD commisures are often defective. When the sdn-1 mutation is 
present in the genetic background of mutants for heparan sulphate synthesis (hse-5(tm472) and hst-
6(ok273)), the DD defects occur at much higher rate. This finding suggested that deficiency of another 
heparan sulphate proteoglycan might be responsible for it and agrin was a possible candidate. 
We investigated transgenic strains expressing GFP in DD neurons (OxIs12 array) and examined young 
larvae for DD commissural defects. Of the six commissures, which form during embryonic development, 
the first commissure migrates circumferentially on the left side, the other five on the right, and can relatively 
easily be traced. The results are presented in the Fig. 36. The agrin single mutants (either agr-1(eg1770) or 
agr-1(tm2051)) did not show significant defects and an agr-1(eg1770); sdn-1(zh20) double mutants did not 
show a stronger phenotype than the sdn-1(zh20) single mutant, thus suggesting that agrin is not involved in 
commissural axon guidance. 
Hengartner and collaborators scored other neuron-types for defects caused by sdn-1 mutations [101]. Axons 
of the PVQ tail neurons in wild type animals run on both sides of the hypodermal ridge along the ventral 
midline of the worm (PVQL and PVQR, on the left and right side, respectively). Normally, they do not 
cross over, but in sdn-1 mutants left and right fasciculation is lost and the axons do cross over the midline. 
We were interested to test whether the agrin mutation has an overt impact on the rate of the PVQ defects 
when present in a sdn-1 mutant background. No significant difference could be observed neither in the agr-
1 single mutant nor in the double mutant agr-1(tm2051); sdn-1(zh20) (Fig. 37).  
Based on the results of these neuron migration and pathfinding experiments, we could conclude that agrin 
does not have an important role in axon guidance in C. elegans. 
 
 
 88 
Unpublished Results 
 
 
 
Fig 36. DD neuron circumferential guidance is not impaired due to agrin mutations. Number of successful 
commissural reach was scored in different mutant strains. Agrin mutation in sdn-1 background does not 
cause reduction in commissural reach. 
 
 
 
Fig 37. PVQ neuron guidance is not influenced by agrin mutation. Percent of PVQ cross-over was scored 
for agrin and syndecan mutants. No significant defect is caused by agr-1, either alone or with sdn-1. 
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IV. Discussion 
The work presented in this thesis was done during four years, in the joint effort and true team work with 
several remarkable people: Dr. Stefano Canevascini and Gordon Lau under the supervision by Dr. Ruth 
Chiquet-Ehrismann. This discussion, therefore, refers to “our”, not “my” results. 
IV.1. Our quest  
We have decided to work on agrin in C. elegans with the goal to clone the gene and characterize this protein 
in the invertebrate model organism. Since a lot was already known about the functions of agrin in 
vertebrates, but nothing in simpler organisms, we aimed to learn more about this important protein and 
position it in the big picture through an evolutionary perspective.  
Agrin is crucial for the assembly and maintenance of the neuromuscular junction (NMJ) in vertebrates, 
(reviewed in [13,140]). Its null mutation in mice is lethal [38], but in man no known genetic disease has 
been assigned to any mutation in the agrin gene. The reason might be that agrin is essential already during 
very early embryonic development. Interestingly, despite more than two decades of extensive search for the 
direct signaling downstream of agrin, only some molecular players and fragments of the pathways have 
been elucidated so far. It is clear that agrin activates the muscle receptor tyrosine kinase MuSK, but only 
indirectly, through binding to a yet unidentified receptor. According to some speculations, the “hypothetical 
receptor” might as well be a modification of MuSK, its dimerization, or even a bigger complex with more 
components involved, reviewed in [13]. This big “question mark” in the studies of vertebrate agrin certainly 
was a part of our motivation for studying it in a simple model organism. We aimed to see if agrin function 
was conserved in C. elegans and to explore its great genetic potential to identify the missing links. 
IV.2 The molecular structure of C. elegans agrin is significantly similar to the vertebrate homologue 
We have cloned the agr-1 cDNA on the basis of the prediction published by Dr. Harald Hutter [117] and the 
sequence from the Wormbase (http://www.wormbase.org), the online C. elegans database. Despite the 
original prediction of two open reading frames, we identified only one unique agrin sequence composed of 
the two predicted sequences. The size of the gene, comprising 4422 bp, was not surprising since all the 
known vertebrate orthologs are relatively large. In distinction to the vertebrate agrin, we could identify only 
one isoform containing a putative cleaved signal sequence, but without any potential domain similar to the 
laminin-binding NtA domain in vertebrates. Therefore worm agrin may not bind to laminin in the basement 
membrane (BM), or it could be binding to it through another domain. Other possibility is that it interacts 
with laminin indirectly, via other proteins. This, still open question, could be addressed in the future by 
 90 
Discussion 
affinity studies with the N-terminal and central part of the molecule as “protein baits”. The overall protein 
structure of C. elegans agrin is relatively conserved compared to the vertebrates. The lack of serine-
threonine (S/T) rich regions in the central part of the molecule could be affecting its glycosylation profile. 
Since in vertebrate agrin there are several confirmed attachment sites for the O-linked carbohydrate 
modifications, one would expect that C. elegans agrin does not carry such glycosamino glycan chains (GAG) 
chains. Nevertheless, our analysis of the proteins in C. elegans lysates by western blotting, resulted in a 
band about the predicted size of agrin (160 kDa) plus a smear that could correspond to its glycosylation. 
Several potential attachment sites for N-linked glycosylation were identified by computer analysis of the 
protein sequence, but would have to be confirmed by the enzymatic treatment with specific deglycosylating 
enzymes. 
Since in vertebrates the three lam G domains at the C-terminus play a very important part in the NMJ 
signaling [27], it was striking that C. elegans agrin actually has only two of them. BLAST searches with 
each of the domains separately indicated that the two AGR-1 lam G domains correspond to the second and 
the third domain of the vertebrate agrin homologues. We can postulate that the first lam G of vertebrate 
agrin was acquired later in evolution and brought a new interaction site to the molecule. Despite the fact that 
the AGR-1 lam G domains correspond to the vertebrate agrin lam G domains, no alternative splicing could 
be found at the conserved sites. Considering that the alternative splicing gives rise to the isoforms with 
significantly different AChRs clustering activity [23], we assumed that, if AGR-1 had an analogous function, 
the splicing inserts would be present. Contrary to the expected, we could neither identify any alternative 
splicing nor any potential exons in the genomic sequence in that region, that would encode the conserved 
amino acid inserts. We could conclude that AGR-1 exists in a single isoform, which probably corresponds 
to the vertebrate A0B0 splice variant. Another possibility, that can not be completely neglected, is that there 
might be another isoform, expressed at a significantly lower level, which was undetectable in the presence 
of the isoform that we identified. 
IV.3. The agr-1 expression pattern in the head neurons and pharyngeal epithelium was unexpected 
Transgenic worm strains carrying reporter constructs, that encoded fluorescent proteins under varying 
portions of the agr-1 promoter, revealed agrin expression in the buccal epithelium, IL1 head neurons, and 
the distal tip cells (DTCs) of developing gonads. To our surprise, no expression was detected in the body 
wall muscles or motoneurons innervating them, as would be expected by analogy to vertebrates. 
Nevertheless, we could not exclude the possibility that the expression level was under the detection 
threshold. The immunofluorescence data, with both monoclonal and polyclonal anti-agrin antibodies, 
supported the expression pattern analyzed by reporter genes. No staining was seen in the body wall muscles 
 91
Discussion 
and the motoneurons. Since the permeabilization and immunostaining of C. elegans often present 
substantial technical difficulties, we have used anti-myosin, anti-perlecan and anti-rim (pan-neuronal marker) 
antibodies as positive controls to verify the experimental success. AGR-1 was detected around the pharynx, 
presumably in its basement membrane, because the staining resembled the perlecan localization in that 
region. We propose that agrin is expressed by the epithelial cells and secreted and deposited in the 
pharyngeal basement membrane.  
No immunostaining was detected in the four IL1 neurons. In case agrin is secreted from these cells, we 
would expect it to be localized in a small region at the tips of the dendrites (in the inner labial sensilla 
around worm’s mouth) or at the axonal endings in the nerve ring. Such a low level of expression would 
require detection at a much better resolution, possibly even by electron microscopy. The IL1 neurons make 
synapses to the RMD motoneurons in the nerve ring, a neuropile around the worm’s pharynx [93]. 
Additionaly, the IL1 neuron were shown to synapse with RIP pharyngeal neurons, the only ones receiving 
extrapharyngeal input [93,119]. 
IV.4. Agrin function is dispensable for C. elegans under laboratory conditions 
In order to investigate agrin function in the worm we analyzed several strains carrying mutations in the agr-
1 gene. Two mutants were molecular null because of the Mos1 transposon insertion (eg1770) and its 
imprecise excision (eg153) [170], while one strain had a short in-frame deletion of the exons 26 and 27 at 
the C-terminus (tm2051). Based on the well known function of agrin at the vertebrate NMJ, we expected 
that the C. elegans agr-1 mutants would have locomotory defects due to defective NMJ synapses. Despite 
the unexpected expression pattern and immunostaining that never revealed any relation to body muscles and 
motoneurons, we studied typical functions that could be impaired due to NMJ defects. With that goal we 
performed locomotion studies on plates and in liquid (thrashing assay), pharmacological assays commonly 
used to score NMJ mutants (i.e. levamisole and aldicarb), and egg-laying experiments. We did observe a 
very mild resistance to levamisole at very low concentrations (i.e. 0.25 mM) which could be compared to 
the phenotype of the lev-10 mutant, resistant at levamisole conc. ≤ 0.8 mM  [112]. Nevertheless, the 
standard deviations were in our case too high to have a clear and reproducible result that would undoubtedly 
indicate an AGR-1 function at the NMJ analogous to vertebrates. In parallel with the in vivo experiments, 
we performed in vitro clustering assays with a recombinant AGR-1 fragment and mouse myotubes. 
Although some AChR clustering could be observed, it was induced only with the highest concentration of 
the fragment, at approximately 100 times more than the vertebrate A4B8 positive control. Taken together, 
these data indicate that in C. elegans agrin does not play a crucial role in AChR clustering at the NMJ. 
Interestingly, the phenotype of lev-10 mutants could be rescued by overexpression of its extracellular 
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domain alone, suggesting that the AChR clustering mechanism in C. elegans might be regulated through a 
significantly different pathway than in vertebrates. These initial findings were quite surprising, and 
unexpected for us. 
Another very important function of agrin in the entire muscle basement membrane is to provide structural 
support to the muscle by connecting the ECM to the cellular cytoskeleton through the DGC complex [65,66]. 
It is well known that mutations in components of this supramolecular complex lead to the outcome of 
muscular dystrophies (for a review, see [62]). Although we did not find any AGR-1 expression in C. elegans 
muscles, we considered that it could be below the detectable levels and investigated its impact on muscle 
structure. Since agrin alone did not cause any visible morphological changes in the muscles, as we could 
visualize by reporter constructs overexpressed under the muscle-specific promoters (myoD), we created 
several mutant strains with mutations in other BM and ECM proteins. None of the combinations caused 
morphological or behavioral defects that would suggest an AGR-1 function in the worms’ muscles.  
Since agrin was found to be expressed in four IL1 head neurons, we expected that its function might be 
related to them. There are three pairs of IL1 neurons, all polymodal by type: mechanosensory, interneurons 
and motoneurons, known to be involved in spontaneous foraging and the head withdrawal reflex as a 
response to light nose touch [98]. Worms in which the IL1 neurons were laser-ablated, forage abnormally 
slowly and show over-bending of the head. We scored the worms for the sensation of the light nose touch by 
the “eyelash test”, but did not notice any resistance in agr-1 mutants as compared to the wild type. We could 
conclude that agrin does not have a crucial role in the IL1 cells, although we could not exclude that it could 
have a sensory function compensated by another protein.  
Based on the agr-1 expression pattern in the distal tip cells of a developing gonad, we analyzed whether its 
mutation causes any gonad migration defects that could impact gonad morphology. It is known that several 
signaling pathways play a role in normal gonad development, for example: EGL-17/FGF; UNC-129/TGF-β; 
and EGL-20/WNT [132]. We crossed agr-1(eg1770) mutants with several components of these pathways in 
order to investigate whether agr-1 interacts genetically with any of them leading to a synergistic effect on 
gonad development. We did observe a slight reduction (up to 10%) of the defect rate in the double mutants 
as compared to the single mutants. It seemed that agr-1 slightly suppressed the phenotypes caused by 
mutations in growth factor-like molecules, resembling the effects in the perlecan/unc-52 mutants. Therefore, 
we could speculate that AGR-1 has a role in the gonad development, but to verify it, these experiments 
would have to be repeated with a larger population of worms and by a genotype-blinded analysis in order to 
ensure statistical significance and to avoid bias. Agrin might be important for gonad migration as one of 
many molecular components acting in parallel. 
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Previous studies have demonstrated that ECM and membrane-bound proteins provide signaling cues for 
axon guidance during development of the nervous system. Heparan sulphate proteoglycans (HSPGs) play an 
important part in neuronal development, reviewed in [181]. Since they are essential for many processes in 
the worm, their complete elimination is lethal [182], but partial depletion of only some HS-modyfing 
enzymes (sulfotransferases and epimerases) cause distinct defects in axon guidance [180]. These data point 
to the importance of precise “sugar codes” that axons can follow as they grow and migrate. Null mutations 
in the C. elegans syndecan homologue SDN-1, cause severe defects in axon guidance of many neurons, 
such as HSN motoneurons, PVQ interneurons, and D-type motoneurons (fasciculation and circumferential 
growth) [101].  Interestingly, both of the sdn-1 mutant alleles (zh20 and ok449) in combination with HS-
modifying enzymes, hse-5(tm472) and hst-2(ok595) cause axon guidance defects at a level significantly 
higher than the addition of single-mutant defects. These data suggested that the mutations in HS-modifying 
enzymes affect another HSPG. Since we did observe some AGR-1 immunostaining in the region of the 
ventral and dorsal midline, we suspected that it might play a role in the anteroposterior or circumferential 
axon guidance and represent the missing HSPG. We analyzed the agr-1(eg1770); sdn-1(zh20) double 
mutants, but did not detect any increase in guidance defects as compared to sdn-1 alone. Therefore, we 
could conclude that AGR-1, although it might be modified by the HS-modifying enzymes, does not play an 
important role in axon guidance. 
IV.5. Significance of the identified interacting partners  
Agrin is a large protein, built of different structural modules that provide possibilities for interactions with 
many different proteins, reviewed in [13,67]. Since the interaction with α-dystroglycan (α-DG) is very well 
established, we investigated whether this interaction is conserved in C. elegans as well. The in vitro 
membrane overlay assays undoubtedly indicated that the recombinant AGR-1 fragment, comprising the two 
lamG domains, binds to the purified chicken α-DG [33]. This interesting result was supported by an 
experiment in COS cells transfected with the same AGR-1 recombinant fragment. The transfected cells 
exhibited the secreted agrin fragment on the cell surface, in a patchy pattern overlapping with endogenous 
α-DG, again pointing to an interaction despite the cross-species barriers. Therefore, we speculated that they 
might interact physiologically in vivo. To further investigate this interesting observation, we crossed agr-
1(eg1770) mutants with the dgn-1(cg121) dgn-2(ok209) dgn-3(tm1092) and dgn-2(ok209) dgn-3(tm1092) 
[158]. Contrary to the expected, no obvious phenotypic defects could be seen in the combined mutant strains. 
The dgn-1(cg121) mutation alone causes severe gonad defects and sterility, but even analysed as a rescued 
heterozygote (with a wild type gene on an extrachromosomal array) the agr-1(eg1770) mutation did not 
affect the phenotype. The dgn-2 and dgn-3 are expressed in pharynx and some head neurons, but mutants do 
not have significant phenotypes. Since the expression pattern resembles the agr-1 pattern, we expected that 
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a triple mutant agr-1(eg1770) dgn-2(ok209) dgn-3(tm1092) might have stronger pharynx-related defects. 
Although we did not see a strong defect due to a possible genetic interaction, it would need to be analyzed 
in more detail as it might anyway be present. We consider it as a high probability that AGR-1 and DGN 
genes do interact in vivo, but its significance has to be challenged by finding the appropriate narrow and 
more specific experimental niche. 
Our attempts to identify interaction partners for AGR-1 did not focus only on α-DG. We tried to learn more 
about other putative interacting factors by affinity chromatography experiments. We could identify several 
proteins that selectively bound to the AGR-1 recombinant fragment (of two lamG domains), while they did 
not bind to a control column that served as a negative control. To our disappointment, the mass-
spectroscopy analysis revealed that the interacting proteins were mostly enzymes of the oxido-reductase 
family, involved in fatty acid metabolism. Despite all efforts, we could not make a logical connection that 
would support the physiological relevance of these interactions. Another unexpected fact is that, under the 
experimental set-up that we used, we could not even confirm the interaction with α-DG. A possible 
explanation could be that the recombinant AGR-1 fragment, which we used, did not have the correct sugar 
modification that would mimic the three dimentional structure of the endogenous protein and allow a 
physiological interaction with the endogenous α-DG. 
IV.6. Open questions and possible directions  
Our studies furnished us with interesting insight into the first invertebrate agrin homologue identified so far. 
We demonstrated successfully its expression in the worm, revealed its unexpected expression pattern and 
dissected its possible roles. It is clear that AGR-1 is dispensable for C. elegans because the agr-1 mutants 
grow, move and reproduce normally. Although none of the functional studies that we undertook clearly led 
us to the AGR-1 function, they left substantial basis for possible further experiments. Since negative results 
in experimental research are never completely informative, several of the experimental directions that we 
explored can be pursued further.  
The expression of agr-1 in the IL1 heads neurons suggests its role related to those cells. As mentioned 
earlier, AGR-1 is probably secreted by the dendrites and/or axons, and stays integrated in the basement 
membrane. Despite the computer prediction of the secretion signal and the cleavage site, there is a 
possibility that in IL1 neurons it stays anchored to the cell membrane. The dendrites of the IL1 neurons have 
endings enclosed within the inner labial sensilla cuticle and pass through channels lined with extracellular 
material [183]. Sublocalization of AGR-1 could be investigated by electron microscopy of the labial sensilla 
ECM. If secreted and localized there, agrin could be involved in the fine sensory input. On the other hand, 
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the IL1 axons, projecting into the nerve ring, synapse to the RMD motoneurons, thereby forming neuronal 
circuits for head-withdrawal reflex and spontaneous foraging [98,184]. Since the RMD neurons express 
glutamate receptor glr-1, which if mutated causes defects in the mentioned functions, it would be interesting 
to see if it interacts genetically with agr-1 mutation. The experimental procedure for scoring head 
withdrawal phenotypes is technically demanding, therefore the experimentation would have to be improved.  
The IL1 neurons, together with IL2, URA, and RME, synapse to the RIP pharyngeal neurons [93], the only 
ones that make synaptic connections outside of the pharynx (for a review, see [119]). Therefore, AGR-1 
expressed by the IL1 neurons might be involved in the pharyngeal pumping in combination with many other 
inputs. One way to investigate this possible role of AGR-1 is to record the electrophysiological profile by a 
special procedure developed in the Leon Avery’s lab, called “electropharyngeogram” (EPG) [185]. Despite 
our inability to see the defects in the pharyngeal movements, the fine changes might be recorded by the EPG 
and seen as an altered potential profile compared to the wild type. The experiment should as well be 
repeated at different temperatures, for example 15˚C, 20˚C and 25˚C. 
Another possible phenotype to be tested is the resistance to the potent nematocidal drug ivermectin. 
Ivermectin activates the glutamate-gated chloride channels, resulting in increased chloride permeability and 
toxicity. It was shown that a combination of mutations in three genes is needed to confer resistance to 
ivermectin: glc-1, avr-15 and avr-14 [186]. AGR-1 could possibly be involved in the ivermectin-induced 
toxicity and the mutation might induce slight resistance, either alone, or in combination with some of the 
above mentioned genes.  
Since it was shown recently that agrin in vertebrates binds to the Na+/K+ ATPase in the CNS [75], which has 
an ortholog in C. elegans encoded by eat-6 [122,187], it would be challenging to further investigate if agr-1 
genetically interacts with it. EAT-6 has been implicated in the feeding, since the mutants exhibit slow and 
delayed relaxation of the pharyngeal muscles. The defects are detectable by eye as well as recordable by the 
previously mentioned EPG method [185]. The possible interaction with agr-1 could maybe be seen as an 
altered EPG pattern. 
In addition to analyzing the agr-1 mutants, we tried RNAi-mediated gene knock-down under muscle and 
neuron-specific promoters. Neurons in C. elegans are known to be difficult target for RNAi, therefore it 
might have been more useful to do the experiment in the sensitized strains, such as rrf-1 [188] or eri-1 [189]. 
Conversely, the AGR-1 overexpression specifically in the IL1 neurons would be an interesting approach 
complementary to the mutant analysis. Additionally, an overexpression of a “dominant-negative” mutant, i.e. 
missing the last two lamG domains, in the agr-1 or wt background, would be an interesting experiment. In 
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such experimental setting it might be easier to see the defects, than in a complete null mutant where the loss 
of AGR-1 might be compensated for by other proteins. 
In our attempts to identify more factors interacting with AGR-1, we focused only on the C-terminal 
interactions through the two lam G domains. It would be interesting to overexpress the full length protein 
and search for its interactions with endogenous C. elegans proteins. The reason why our affinity column 
experiments were not very successful might be due to the lack of other necessary domain in our AGR-1 
fragment or the lack of appropriate glycosylation. 
 
Although one part of our goal, to identify the missing links in the agrin-MuSK pathway, was not met, our 
work represents an original and interesting characterization of a novel protein. We successfully identified 
the expression and localization of agrin in C. elegans and undertook significant efforts to elucidate its 
function. Our results clearly demonstrate that between the worm and man there still is a large evolutionary 
gap. Seen from the evolutionary perspective, AGR-1 was probably a protein involved in sensory or 
structural functions, in parallel with several others. It should be noted that no agrin ortholog has been 
identified in Drosophila melanogaster and other proteins are involved in synapse development in insects. 
Since in vertebrate agrin the three lamG domains are functionally the most important part for AChRs 
clustering at the NMJ, the lack of one of these domains in AGR-1 supports the speculation for a completely 
different function. Through evolution, the ancestral AGR-1 molecule might have acquired the third lam G 
domain which developed a new interaction site and gave rise to the new, “evolutionarily younger”, function 
at the NMJ.  
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V. Appendix 
 
V.1. Experimental procedures (unpublished data) 
 
 
In vitro clustering assay of AChRs on muscle myotubes  
[protocol and reagents were  kindly  provided by Prof. Markus Rüegg] 
 
 
? Culture media 
The following media were used for the growth and differentiation of myoblasts: 
 
Growth medium:  
 - DMEM high glucose with Pyruvate with Phenol red 
 - 20 % Foetal Calf Serum 
 - 1% L-Glutamin 
 - 1% Sodium Pyruvate 
 - 1% Penicillin -Streptomycin 
 
Differentiation (fusion) medium: 
 - DMEM high glucose with Pyruvate with Phenol red 
 - 5 % Horse serum 
 - 1%  L-Glutamin 
 - 1% Sodium Pyruvate 
 - 1% Penicillin -Streptomycin 
 
 
 
? Culturing and splitting myoblasts 
 
C2C12 myoblast cells were maintained at low density (not higher than 50% confluency), therefore the 
cultures had to be split every 2-3 days.  
For the clustering assays, C2C12 myoblasts first had to be differentiated by fusion into myotubes. Before 
plating the cells, 3.5cm-tissue culture plates were coated with 0.03% gelatin and kept during at least 30min 
at 37°C. The rest of the liquid was aspirated and 30 000 cells were plated into each dish, in 2 ml of the 
normal growth medium.  
 
 
? Myoblast fusion 
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To induce the fusion of C2C12 myoblasts, the growth medium was replaced by the differentiation medium 
when cells reached approximately 80% confluency (about 2 days after plating). The differentiation medium 
had to be exchanged for the fresh one 2 days later. In total 5 days after the first exchange to the 
differentiation medium, the formed syncytial myotubes and were ready for the clustering assay. 
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? AChRs clustering assay 
 
In order to treat the myotubes and to perform the clustering assay, medium was removed and cells washed 
twice in PBS-. The concentration of the C. elegans recombinant agrin was estimated by the band intensity, 
as compared to the known dilutions of BSA, on the Coomassie stained SDS PAGE gel. The samples were 
prepared in serial dilutions as following: 1/2 (125 ng/µl) ? 1/10 (25 ng/µl)? 1/50 (5 ng/µl) ?1/250 (1 
ng/µl) ?1/500 (0.5 ng/µl), in differentiation medium. Purified recombinant fragments of chicken neuronal 
and muscle agrin were used as positive and negative control, respectively. The concentrations of both 
samples were about 0.5µg/µl, and were diluted 500 times to the final concentration of 1 ng/µl.  
 
The cells were incubated with agrin samples overnight, during approximately 16 hours at 37˚C. The 
following morning, the media were removed, cells rinsed with PBS- and incubated with fluorescently 
labeled α-bungarotoxin (α-Btx) during 30 min at 37˚C, in the dark. 
 
Myotubes were gently washed 3 times in PBS- and fixed in 2% paraformaldehyde during 10 minutes at 
room temperature in the dark. Following washing with PBS-, a drop of mounting medium was added to the 
fixed cells and the samples analyzed under Zeiss Axioscope Bio microscope, with a rhodamine filter. 
 
 
 
Affinity column experiments in search for potential agrin binding factors 
 
 
The affinity column experiments were repeated three times following modifications of the following 
protocol.  
 
? Samples preparation 
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Worms for the preparation of lysates were cultured as described in section III.1. After washing, they were 
frozen and stored at -80°C. For protein extraction, they were ground in liquid nitrogen in a porcelain mortar. 
Initial amounts of frozen worm material varied between experiments (Annex, Table 1). In the three 
successive experiments, different lysis /homogenization buffers were used for the preparation of the 
suspensions (Table 1). In the first experiment the pulverized samples were resuspended in equal volumes of 
ice-cold ddH2O and lysed with the addition of an equal volume of 2x lysis buffer. In the second and third 
experiment the pulverized worms were resuspended in the homogenization buffers. Cocktails of protease 
inhibitors containing EDTA (Complete Mini, Roche) were added to the solutions. The suspensions were 
centrifuged at 10000 g for 20 minutes to separate soluble from insoluble fractions. Following the 
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centrifugation, pellets were resuspended in the lysis buffer and centrifuged again. In the first experiment 
lysis buffer contained protease inhibitors with EDTA, but in the next experiments we used only EDTA-free 
inhibitor cocktails. In the first experiment both supernatants were pooled (Table 1, shaded fields), filtered 
through a 1.2µm filter and split into two batches, one to be used on agrin-containing column and a negative 
control column. In the repeated experiments the first supernatants were discarded and only the second ones 
(without EDTA) were used for the column (Table 1, shaded fields). 
 
 
? Columns preparation 
Binding of the purified agrin fragment to the CNBr-activated SepharoseTM 4B resin beads (Amersham 
Pharmacia) was done following supplier’s protocol. A control column was prepared without agrin and with 
blocking reagent only. Both columns contained equal volume of approx. 2.5 ml of packed beads. And they 
were kept in Column Storage buffer (Table 1) at 4˚C. Before each experiment, they were equilibrated at 
room temperature and prewashed with PBS-, followed by resuspension buffer, wash buffer, elution buffer 
and the end resuspension buffer again. In each experiment a half of the lysate supernatant was loaded on the 
agrin-containing column and the other half to the control column. Binding of the lysate supernatants to the 
beads was done following the supplier’s protocol.   
 
 
? Loading the samples and the analysis 
The samples were loaded at the flow rate of approx. 0.3 ml/min, the columns washed with 15 ml of Wash 
buffer (the composition varied between the experiments, see the table below) and the bound proteins eluted 
and collected in fractions of 0.5 ml with a fraction collector at a flow rate of approx. 1 ml/min. In the first 
experiment no absorbance was measured because of the presence of NP-40 detergent in the Elution buffer. 
Different fractions were analysed by SDS PAGE on Ready Tris-HCl 4-15% linear gradient gels (BioRad) 
and detected by Coomassie Blue staining (Pierce). 
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Table 1. Compositions of the buffers used in three independent affinity column experiments 
 
Step Experiment 1 
(with 8 ml of worms) 
Experiment 2 
(with 4 ml of worms) 
Experiment 3 
(with 10 ml of worms) 
1) 
Lysis 
Or  
Homogenization 
 
 
 
Lysis buffer 1    * 
(2x stock solution): 
Tris pH8  100mM  
NaCl 240 mM 
NP-40 1%  
MgCl2 4 mM  
+ Prot. Inh. w EDTA 
Homogenization buffer 2 (1x) 
PBS-
+ Prot. Inh. w EDTA 1mM 
 
(supernatant discarded) 
Homogenization buffer 2 (1x) 
Tris pH 7.4  50 mM 
NaCl 50 mM 
+ Prot. Inh. w EDTA 
 
(supernatant discarded) 
 
 
2) 
Pellet 
Resuspension 
Buffer  
(as Column 
Binding buffer) 
 
Lysis buffer 1: 
 
As above 
 
(supernatants pooled 
and loaded on the 
column)  
Lysis buffer 2: 
PBS- 
CaCl2 2mM 
MgCl2 1mM 
NP-40 1% 
+ Prot. Inh. w/o EDTA 
 
(supernatant loaded on 
the column) 
Lysis buffer 3: 
Tris pH 7.4  50 mM 
NaCl 50 mM 
CaCl2 2mM 
MgCl2 1mM 
1% NP-40 
+ Prot. Inh. w/o EDTA 
 
(supernatant loaded on 
the column) 
 
3) 
Column 
Washing 
 
 
Wash buffer 1: 
As the Lysis buffer 1 (1x)  
 
Wash buffer 2: 
As the Lysis buffer  2  
 
 
Wash buffer 3: 
As the Lysis buffer 3 
4) 
Column 
Elution 
 
Elution buffer 1: 
As the Lysis buffer 1 (1x) 
with 1M NaCl 
Elution buffer 2: 
PBS-
NaCl 1.8 M 
EDTA 10mM 
Elution buffer 3: 
Tris pH 7.4  50 mM 
NaCl  2M 
EDTA 10mM 
 
 
Other  
solutions 
 
 
Column Storage buffer  
(5x stock solution): 
Borate pH8 (NaOH) 
NaCl 0.75 M 
  
 * the supernatants of the samples in the shaded fields were loaded on the column 
 
 
 
In vivo pharmacological assays – levamisole & aldicarb 
 
? Preparation of the plates: 
Aldicarb was dissolved in 70% EtOH for 100mM stock solution. Levamisole was dissolved in H2O for 
100mM stock solution. The nematode growth medium (NGM) was prepared following the standard 
procedure [163]. After autoclaving and cooling down to 60˚C, aldicarb or levamisole were added to the 
NGM at the desired final concentrations. The solutions were mixed and immediately poored in small 6cm 
plates. 
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? Pharmacological assays 
For each test 20 young adults were picked from a “non-starved” plate and laid in the centre of a test plate, 
with levamisole, aldicarb or an NGM plate without supplements. During the experiment, the plates were 
kept at 21˚C. At one hour intervals the animals were scored for movement (survival). The worms that were 
not able to make a full bend after prodding their tails were considered as “dead”. The test was always 
repeated three times for each strain. Statistical analysis of the scores was done by the Student T test. 
 
 
? Mutant genotypes 
The genotype of the strains for the levamisole test: 
N2 wt 
agr-1(eg1770) 
lev-1(e211) 
 
The genotype of the strains for the aldicarb test: 
N2 wt 
agr-1(eg1770) 
dyb-1(cx36) dys-1(cx18) 
dyb-1(cx36) dys-1(cx18); agr-1(eg1770)  
(two lines of the same genotype were tested in our experiments) 
 
 
 
Analysis of putative agrin function in C. elegans by dsRNA “knock-down” experiments 
 
? Gene cloning and production of dsRNA  
Agrin cDNA was synthesized from total RNA (from mixed-stage population) by SuperScriptTM II Reverse 
Transcriptase kit (Invitrogen) following the supplier’s protocol. For the positive control, a fragment of 
myosin (myo3) cDNA was amplified. Primers and plasmids for the constructs are shown below. 
For the amplification of agrin: 
agr8: CAGTGTGTGGATCAGAAGGAACAG (EcoRI, added to the primer) 
agr9: GCCTCCATCTCATTGTCATTCATC (EcoRI added to the primer) 
The PCR product was digested with EcoRI restriction enzyme and cloned into pBluescriptKSII+ (construct 
P230). The construct was then linearized with XhoI or SpeI for the in vitro RNA synthesis with T7 and T3 
polymerases, respectively. 
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For the amplification of myosin3: 
myo3RNAi1 TTCTGCAGTAACGAGGATCTTGCTCGC  (PstI added to the primer) 
myo3RNAi2 CCACTAGTGGTACCTTCGAGAGAGCGGTTCAAATC (SpeI added to the primer) 
The PCR product was digested with PstI and SpeI restriction enzymes and cloned into pBluescriptKSII+ 
(construct P227). The construct was then linearized with PstI for the RNA in vitro transcription with T7 
Polymerase or SpeI linerized for the RNA in vitro transcription with T3 Polymerase. 
The single-stranded RNA was produced by in vitro transcription using T7 RiboMAXTM Express RNAi 
System (Promega) following the supplier’s protocol. The two complementary ssRNA were then annealed 
and EtOH precipitated/purified.  
 
? Microinjection of the dsRNA into gonads of worms 
In vitro transcribed and annealed dsRNA was resuspended in 1x injection buffer: 20mM K3PO4, 20g/L 
PEG6000, 3mM KCitrate, pH 7.5, at an approximate final concentration of 200ng/µl. The dsRNA was 
injected in the gonads of young adults using an Eppendorf Femto Jet system for microinjections under a 
Zeiss Axiovert 10 microscope. Only animals for which the gonad filling was observed under the microscope 
were kept. The worms were put back on NGM plates, with E. coli (OP50) bacteria, to recover for 8 hours 
and then subsequently only  healthy animals were transferred to a new NGM plate (one animal per plate).  
 
? Analysis of the phenotypes 
The progeny of the microinjected animals was scored for the following phenotypes: embryonic lethality 
(dead eggs), larval lethality, morphological defects, locomotion, and response to touch (nose and tail).  
 
Crosses  
 
? Agrin mutant (agr-1) with Acetycholine esterase (AChE) mutants (ace-1;ace-2) 
 
The agrin mutant strain agr-1(eg1770) was left for 4 hours at 30˚C to raise the relative number of male 
progeny. Males from the progeny were crossed back to the agr-1(eg1770) hermaphrodites in order to 
maintain them. Agr-1(eg1770) males from the next generation were crossed with ace-1(p1000); ace-2(g72) 
double-mutant hermaphrodites, by putting them on an empty NGM plate with only a little bacteria in the 
middle of the plate. Three days later, 12 coordinated worms were cloned form the progeny. Since 
homozygous ace-1(p1000); ace-2(g72) mutants are uncoordinated (unc), all cross-progeny with agr-1 was 
expected to be heterozygous, i.e. coordinated. Each cloned worm was grown on a separate plate, left to lay 
eggs, and then picked for genotyping. The worms were frozen, each in one tube, in 2µl of the lysis buffer 
(10mM Tris pH8.0, 50mM KCl, 0.5% NP-40, 0.5% Tween-20, 0.01% gelatine, 0.1 mg/ml Proteinase K), 
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thawed and then lysed at 60˚C during 1 hour followed by 15 min at 94˚C for the inactivation of the 
Proteinase K enzyme. PCR was done directly by the addition of 18µl of a master mix. If PCRs for more 
genes had to be done from the same worm, the worm was lysed in bigger volume of the lysis buffer and the 
lysate aliquoted for the separate PCRs. 
 
Master mix:     final 
      concetration 
ddH2O        13.3 µl 
HiFi reaction buffer (10x, company)  1x  2 µl 
dNTP mix (each dNTP 10mM, Eppendorf) 2mM  0.4 µl 
Primers mix (2mM each)   200nM  2 µl 
Expand HiFi polymerase, Roche (3.5U/µl) 1U/mix 0.3 µl 
Total mix volume      18 µl 
Total reaction volume      20 µl 
 
Primers for genotyping the agr-1(eg1770) allele were the following: 
Agr6  TGGGCATACACATTTGGGTTTTCCG 
AgrMos GCTGCCTGCAAGGAACAAAAGG 
Mos2  GCATTCGGTGCGATTCCGCAG 
Primers for genotyping the ace-1(p1000) allele were the following: 
Ace1-5’ GCTGTTGATCTCATTCACCTC
Ace1-3’ TCACGTCATTCTAATCTGTTGC
Primers for genotyping the ace-2(g72) allele were the following: 
Ace2-5’ GATTAGTTTATGACAAAAATTG   
Ace2-3’ GTCGAAATTGATGCAAATGG  
The PCR amplification was done in 35 cycles, with the annealing temperature set to 55˚C for all three genes, 
and the elongation time to 1min 30sec. The sizes of the resulting PCR products were the following: for agrin 
Wt allele 400 bp and agr-1(eg1770) 700 bp. Ace-1(p1000) and ace-2(g72) carry point mutations, therefore 
mutant alleles could not be distinguished from the Wt by size on the agarose gel, for ace-1 the PCR product 
was 400 bp long, for ace-2 800 bp. Since the point mutation in ace-1(p1000) causes an alteration of a 
restriction site, we analysed the PCR product by digestion with the BslI restriction enzyme. The fragment 
was purified from the PCR mix with the PCR Purification Kit from Qiagen, following the supplier’s 
protocol, and digested with BslI (5U) during 1h 30min at 55˚C. The digestion of the ace-1 wild type allele 
gave fragments of 230 bp, 180 bp, and 80 bp, and for the mutant 410bp and 80bp. PCR products of the ace-
2 allele had to be gel-purified and sequenced. 
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? Agrin mutant (agr-1) with Dystroglycan mutants (dgn-1;dgn-2;dgn-3) 
 
The general procedure of the cross was done as described above, with additional modifications. Since dgn-1; 
dgn-2; dgn-3 triple mutants are sterile, they were balanced with the wild type copy of the dgn-1 gene on an 
extrachromosomal array, which as well carried the roller gene rol-6mut (pRF4) and the pdgn-1::gfp as 
markers. Therefore, only green roller worms were fertile. During the cross we cloned only the green rollers 
and genotyped them. For dgn-1 two different PCRs were done in order to distinguish between the wt and 
mutant alleles in heterozygotes. 
 
Primers for genotyping dgn-1(cg121) allele were the following: 
Dgn 1 A CTAGTGACAACCGCCATTTCCG  [ upstream of the deletion region] 
Dgn 1 B GAATTCCAAAGGCTCAGAGAGC  [downstream of the deletion region] 
With dgn 1A & dgn 1B primers, deletion mutant dgn-1 allele gives a band of 397 bp and the wild type 2792 
bp (not distinguishing between genomic DNA and the extrachromosomal array) 
Dgn 1 D AATGTGAAAGGTAGTGCCAGGC  [ downstream of the deletion region] 
Dgn 1 E TTCCCACCAACACAATCCCAC   [within the deletion region] 
With dgn 1D & dgn 1E primers, only wild type allele on genomic DNA gives a band of 1000 bp. 
 
Primers for genotyping dgn-2(ok209) allele were the following: 
Dgn 2 A  CATCCATTCGGCAGATGCTACC  [upstream of the deletion region] 
Dgn 2 B AAGAGACGCAGACTTCTCAACC [downstream of the deletion region] 
Dgn 2 C GATTTTGACATCACCGGCTTGG  [within the deletion region] 
Deletion mutant allele dgn-2 with primers dgn2A and dgn2B gives a band of 577 bp. 
Wild type dgn-2 gene with primers dgn2A and dgn2C gives a band of 805 bp. 
 
Primers for genotyping dgn-3(tm1092) allele were the following: 
Dgn 3 A  CATCTCCTCAGTCAATGGTTCG  [upstream of the deletion region] 
Dgn 3 B AGCCTAAGCCTAAACTGGAACC [downstream of the deletion region] 
Dgn 3 C  GGTACACTATTGTGAGATGGGC [within the deletion region] 
Deletion mutant allele dgn-3 with primers dgn3A and dgn3B gives a band of 526 bp. 
Wild type dgn-3 gene with primers dgn3A and dgn3C gives a band of 796 bp. 
 
The lysis and the PCRs were done as described above. PCRs were done with Taq polymerase from Roche.  
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V.2. List of Abbreviations 
 
agr  agrin gene in C. elegans 
ACh  neurotransmitter acetylcholine 
AChE  acetylcholine esterase 
AChR  acetylcholine receptor 
APC  antigen presenting cell 
α-DG   α-dystroglycan  
BL  basal lamina 
BM  basement membrane 
bp  base pairs 
CK2  casein kinase 2 
CNS  central nervous system 
DGC  dystrophyn-associated glycoprotein complex 
DTC  distal tip cell 
Dvl  dishevelled 
ECM  extracellular matrix 
EGF  epidermal growth factor 
FS  follistatin-like domains 
GAG  glycosaminoglycan 
HS  heparan-sulphate 
lamG  laminin globular doman 
LE  laminin EGF-like domains 
lev  levamisole-resistant mutants 
LN  long amino (N)-terminal agrin isoform 
MASC  myotube-associated specificity component 
MuSK  muscle-specific kinase 
myd  myodystrophy mouse model 
NMJ  neuromuscular junction 
NKA  Na+/K+-ATPase 
NtA  amino (N)-terminal agrin domain 
PAK  p21-activated kinase 
pat  mutants with paralysis at two-fold embryonic stage 
PCP  planar cell polarity pathway  
PTB  phosphotyrosine-binding 
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RATL  rapsyn-associated transmembrane linker  
SEA  sperm protein, enterokinase, and agrin domain 
SN  short amino (N)-terminal agrin isoform 
S/T  serine/thereonine-rich regions 
TM  transmembrane [agrin isoform] 
TN-C  tenascin C 
Unc  uncoordinated mutants 
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